Anita Deswal, MD, MPH, MBBS

Peer-Reviewed Articles

1. Slivnick JA, Hawkes W, Oliveira J, Woodward G, Akerman A, Gomez A, Hamza I, Desai VK, Barrett-O'Keefe Z, Grogan M, Dispenzieri A, Scott CG, Davison HN, Cotella J, Maurer M, Helmke S, Scherrer-Crosbie M, Soltani M, Goyal A, Zareba KM, Cheng RK, Kirkpatrick JN, Kitano T, Takeuchi M, Tiemi Hotta V, Campos Vieira ML, Elissamburu P, Ronderos RE, Prado A, Koutroumpakis E, Deswal A, Pursnani A, Sarswat N, Patel AR, Addetia K, Ruberg FL, Randazzo M, Asch FM, O'Driscoll J, Al-Roub N, Strom JB, Kidd L, Cuddy S, Upton R, Lang RM, Pellikka PA. Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool. Eur Heart J, 2025. PMID: 40631729.
2. Ynalvez LA, Iliescu CA, Hamzeh IR, Deswal A, Palaskas NL. Treating a Metastatic Pericardial Tumor. JACC Case Rep 30(17), 2025. e-Pub 2025. PMID: 40615195.
3. Khadke S, Kumar A, Bhatti A, Dani SS, Al-Kindi S, Nasir K, Virani SS, Upadhyay J, Garcia-Banigan DC, Abraham S, Husami R, Kong Y, Labib S, Venesy D, Shah S, Lenihan D, Vaduganathan M, Deswal A, Fonarow GC, Butler J, Nohria A, Kosiborod MN, Ganatra S. GLP-1 Receptor Agonist in Non-obese Patients with Type-2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction. J Card Fail S1071(7):989-1001, 2025. e-Pub 2024. PMID: 39667523.
4. Fatakdawala MM, Ali HR, Song J, Irizarry-Caro JA, Faiz SA, Kumar S, Yusuf SW, Durand J, Iliescu C, Palaskas N, Deswal A, Koutroumpakis E. Correlation of Natriuretic Peptides with Invasively Measured Intracardiac Filling Pressures in Patients With Cancer. JACC: CardioOncology 7(4):448-450, 2025. PMID: 40366327.
5. Ruiz JI, Zhao B, Palaskas N, Deswal A, Zhao H, McQuade J, Suarez-Almazor ME. Major Adverse Cardiovascular Events in Patients with Melanoma Receiving Immune Checkpoint Inhibitors. J Immunother Precis Oncol 8(2):1-9, 2025. e-Pub 2025. PMID: 40224298.
6. Palaskas, NL, King, NE, Ostos-Mendoza, KC, Ruiz-Jurado, A, Ali, HR, Koutroumpakis, E, Deswal, A, Iliescu, C, Durand, J, Karimzad, K. Pacing Solutions for Immune Checkpoint Myocarditis and Associated Conduction Disorders. JACC: Case Reports 30(8), 2025. e-Pub 2025. PMID: 40250924.
7. Abe J, Chau K, Mojiri A, Wang G, Oikawa M, Samanthapudi VSK, Osborn AM, Ostos-Mendoza KC, Mariscal-Reyes KN, Mathur T, Jain A, Herrmann J, Yusuf SW, Krishnan S, Deswal A, Lin SH, Kotla S, Cooke JP, Le NT. Impacts of Radiation on Metabolism and Vascular Cell Senescence. Antioxid Redox Signal. e-Pub 2025. PMID: 40233257.
8. Rao, SV, O'Donoghue, ML, Ruel, M, Rab, T, Tamis-Holland, JE, Alexander, JH, Baber, U, Baker, H, Cohen, MG, Cruz-Ruiz, M, Davis, LL, De Lemos, JA, DeWald, TA, Elgendy, IY, Feldman, DN, Goyal, A, Isiadinso, I, Menon, V, Morrow, DA, Mukherjee, D, Platz, E, Promes, SB, Sandner, S, Sandoval, Y, Schunder, R, Shah, B, Stopyra, JP, Talbot, AW, Taub, PR, Williams, MS, Jneid, H, Beavers, CJ, Beckie, TM, Blankenship, JC, Diercks, DB, Lo, BM, Louis, C, Merchant, FM, Nazir, NT, So, DY, Tomey, M, Welt, F, Otto, CM, Beckman, JA, Armbruster, A, Blumer, V, De Las Fuentes, L, Deswal, A, Ferrari, V, Fremes, SE. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Circulation 151(13):e771-e862, 2025. e-Pub 2025. PMID: 40014670.
9. Ali A, Koutroumpakis E, Song J, Booser D, Barcenas CH, Tripathy D, Barac A, Palaskas NL, Deswal A. Risk Stratification for Trastuzumab-Induced Cardiac Dysfunction and Potential Implications for Surveillance. JACC CardioOncol 7(3):203-215, 2025. e-Pub 2025. PMID: 40246379.
10. Anderson E, Choi Y, Buchsbaum RJ, Klein A, Ky B, Landsburg D, Durani U, Ruddy KJ, Yu AF, Leong D, Asnani A, Neilan TG, Ganatra S, Bloom M, Barac A, Yang EH, Deswal A, Cheng RK, Weiss M, Evens AM, Kahl B, Friedberg JW, Parsons SK, Upshaw JN. Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure. Leuk Lymphoma. e-Pub 2025. PMID: 40195874.
11. Chen YC, Dolladille C, Rao A, Palaskas NL, Deswal A, Lehmann L, Cautela J, Courand PY, Hayek S, Zhu H, Cheng RK, Alexandre J, Baldassarre LA, Roubille F, Laufer-Perl M, Asnani A, Ederhy S, Tamura Y, Francis S, Gaughan EM, Johnson DB, Flint DL, Rainer PP, Bailly G, Ewer SM, Aras MA, Arangalage D, Cariou E, Florido R, Peretto G, Itzhaki Ben Zadok O, Akhter N, Narezkina A, Levenson JE, Liu Y, Crusz SM, Issa N, Piriou N, Leong D, Sandhu S, Turker I, Moliner P, Obeid M, Heinzerling L, Chang WT, Stewart A, Venkatesh V, Du Z, Yadavalli A, Kim D, Chandra A, Zhang KW, Power JR, Moslehi J, Salem JE, Zaha VG, Myocarditis Registry II. Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction. JACC CardioOncol 7(3):234-248, 2025. PMID: 40246381.
12. Rao VU, Deswal A, Lenihan D, Dent S, Lopez-Fernandez T, Lyon AR, Barac A, Palaskas N, Chen MH, Villarraga HR, Sadler D, Campbell CM, Skurka K, Wagner MJ, Totzeck M, Ruddy KJ, Heidenreich P, Thomas R, Addison D, Ganatra S, Cheng R, Reeves D, Ghosh AK, Herrmann J. Quality-of-Care Measures for Cardio-Oncology: An IC-OS and ACC Cardio-Oncology Leadership Council Perspective. JACC CardioOncol 7(3):191-202, 2025. e-Pub 2025. PMID: 40246378.
13. Ali, HR, Cui, S, Sahay, S, Grosu, HB, Riben, MW, Deswal, A, Mouhayar, E, Iliescu, C, Ali, A, Faiz, S. Pulmonary Tumor Thrombotic Microangiopathy. JACC: Case Reports 30(5), 2025. e-Pub 2025. PMID: 40054931.
14. Ali HJ, Cui S, Sahay S, Grosu HB, Riben MW, Deswal A, Mouhayar E, Iliescu C, Ali A, Faiz SA. Pulmonary Tumor Thrombotic Microangiopathy: A Rapidly Progressive Form of Pulmonary Hypertension in Cancer Patients. JACC Case Rep 30(5):103194. e-Pub 2025. PMID: 40054931.
15. Koutroumpakis, E, Naser, M, Mohamed, AS, Eraj, SA, Jarre, A, Shiao, J, Kamal Jomaa, M, Perni, S, Phan, J, Morrison, WH, Frank, SJ, Gunn, GB, Garden, AS, Deswal, A, Abe, J, Rosenthal, D, Mouhayar, E, Fuller, C. Detection of alteration in carotid artery volumetry using standard-of-care computed tomography surveillance scans following unilateral radiation therapy for early-stage tonsillar squamous cell carcinoma survivors. Clinical and Translational Radiation Oncology 51, 2025. e-Pub 2025. PMID: 39867727.
16. Ostos-Mendoza, KC, Saraiba-Rabanales, V, Gutierrez-Gallegos, P, Wang, E, Koutroumpakis, E, Kumar, S, Khalaf, SZ, Ali, HR, Deswal, A, Palaskas, NL. Immune checkpoint inhibitor-associated myocarditis. Journal of Cardiovascular Aging 5(1), 2025. e-Pub 2025.
17. Palaskas NL, King NE, Ostos-Mendoza KC, Ruiz-Jurado A, Ali HJ, Koutroumpakis E, Deswal A, Iliescu C, Durand JB, Karimzad K. Pacing Solutions for Immune Checkpoint Myocarditis and Associated Conduction Disorders. JACC Case Rep. e-Pub 2025. PMID: 40250924.
18. Bloom MW, Vo JB, Rogers JE, Ferrari A, Nohria A, Deswal A, Cheng RK, Kittleson MM, Upshaw JN, Palaskas N, Blaes A, Brown SA, Ky B, Lenihan D, Maurer MS, Fadol A, Skurka K, Cambareri C, Chauhan C, Barac. Cardio-Oncology and Heart Failure: AL Amyloidosis for the Heart Failure Clinician A Supplement to the Scientific Statement from the Heart Failure Society of America. J Card Fail 31(2):456-463, 2025. e-Pub 2024. PMID: 39414560.
19. Deswal A, Bloom MW, Vo JB, Rogers JE, Ferrari A, Nohria A, Deswal A, Cheng RK, Kittleson MM, Upshaw JN, Palaskas N, Blaes A, Brown SA, Ky B, Lenihan D, Maurer MS, Fadol A, Skurka K, Cambareri C, Chauhan C, Barac. Cardio-Oncology and Heart Failure: A Scientific Statement from the Heart Failure Society of America. Journal of Cardiac Failure 31(2):415-455, 2025. e-Pub 2024. PMID: 39419165.
20. Bonaca MP, Lang NN, Chen A, Amiri-Kordestani L, Lipka L, Zwiewka M, Strnadova C, Klaar S, Dent S, Janicijevic TK, Herrmann J, Barac A, de Boer RA, Deswal A, Schou M, Neilan TG, van der Meer P, Moslehi J, Kondapalli L, Ky B, Fernandez TL, Cornell RF, Flaig TW, Hsia J, Sharon E, de Azambuja E, Seltzer J, Januzzi JL, Petrie MC. Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology Primer. JACC CardioOncol 7(2):83-95, 2025. e-Pub 2025. PMID: 39967209.
21. Gaulin C, Jain P, Nair R, Iyer SP, Lee HJ, Fayad L, Feng L, Ok CY, Kanagal-Shamanna R, Oriabure O, Chen W, Xu G, Deswal A, Iliescu C, Badillo M, Ky M, Avellaneda M, Tangc G, Medeiros LJ, Vega F, Flowers CR, Wang ML. Phase 2 trial of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma. Leuk Lymphoma, 2025. PMID: 39838574.
22. Vazquez González NA, Le NT, Palaskas NL, Nead KT, Eutsey LP, Samanthapudi VSK, Osborn AM, Lee J, Mejia G, Hoang O, Lin SH, Deswal A, Herrmann J, Wang G, Kirkland JL, Krishnan S, Wehrens XHT, Chini EN, Yusuf SW, Iliescu CA, Jain A, Burks JK, Seeley E, Lorenzi PL, Chau KM, Ostos Mendoza KC, Grumbach IM, Brookes PS, Hanssen NMJ, de Winther MPJ, Yvan-Charvet L, Kotla S, Schadler K, Abe JI. Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease. Arterioscler Thromb Vasc Biol 45(3):372-385, 2025. e-Pub 2025. PMID: 39817327.
23. Ahmed O, King NE, Qureshi MA, Choudhry AA, Osama M, Zehner C, Ali A, Hamzeh IR, Palaskas NL, Thompson KA, Koutroumpakis E, Deswal A, Yusuf SW. Non-bacterial thrombotic endocarditis: a clinical and pathophysiological reappraisal. Eur Heart J 46(3):236-249, 2025. e-Pub 2024. PMID: 39565324.
24. Deswal A, Naser MA, Radwan Mohamed AS, Eraj SA, Jarre A, Shiao JC, Kamal M, Perni S, Phan JP, Morrison WH, Frank SJ, Gunn GB, Garden AS, Deswal A, Abe JI, Rosenthal DI, Mouhayar E, Fuller CD. Detection of alteration in carotid artery volumetry using standard-of-care computed tomography surveillance scans following unilateral radiation therapy for early-stage tonsillar squamous cell carcinoma survivors: a cross-sectional internally-matched carotid isodose analysis. Clin Transl Radiat Oncol. e-Pub 2025. PMID: 39867727.
25. Bhatti, AW, Patel, R, Dani, SS, Khadke, S, Makwana, B, Lessey, C, Shah, J, Al-Husami, Z, Yang, EH, Thavendiranathan, P, Neilan, TG, Sadler, D, Cheng, RK, Dent, S, Liu, JE, López-Fernández, T, Herrmann, J, Scherrer-Crosbie, M, Lenihan, DJ, Hayek, SS, Ky, B, Deswal, A, Barac, A, Nohria, A, Ganatra, S. SGLT2i and Primary Prevention of Cancer Therapy–Related Cardiac Dysfunction in Patients With Diabetes. JACC: CardioOncology 6(6):863-875, 2024. e-Pub 2024. PMID: 39801650.
26. Koutroumpakis E, Venkatesh N, Aparicio A, Song J, Panaretakis T, Deswal A, Logothetis CJ, Frigo DE, Hahn AW. Leptin levels are associated with coronary artery calcification in patients with advanced prostate cancer. Oncologist. e-Pub 2024. PMID: 39557398.
27. Koutroumpakis E, Patel R, Khadke S, Bedrosian A, Kumar A, Kong Y, Connell B, Upadhyay J, Dani SS, Hahn AW, Logothetis CJ, Al-Kindi S, Butler J, Nohria A, Ganatra S, Deswal A. Associations of SGLT2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone Therapy. Cardiovasc Drugs Ther. e-Pub 2024. PMID: 39527237.
28. Abu Rmilah A, Adham A, Ikram-Ul H, Alzu'bi H, Nandan A, Jouni H, Hirashi S, Owen D, Deswal A, Lin SH, Abe JI, Chao TC, Browne J, Leiner T, Laack N, Herrmann J. Novel risk score for predicting acute cardiovascular and cerebrovascular events after chest radiotherapy in patients with breast or lung cancer. Eur J Prev Cardiol, 2024. e-Pub 2024. PMID: 39453776.
29. Ali, A, Lu, Y, Khalaf, SZ, Iliescu, C, Koutroumpakis, E, Yusuf, SW, Siddiqui, BA, Subudhi, SK, Deswal, A, Palaskas, NL. Use of positron emission tomography for the diagnosis of immune-checkpoint inhibitor| myocarditis. Journal of Nuclear Cardiology 39, 2024. e-Pub 2024. PMID: 39053574.
30. Bhatti AW, Patel R, Dani SS, Khadke S, Makwana B, Lessey C, Shah J, Al-Husami Z, Yang EH, Thavendiranathan P, Neilan TG, Sadler D, Cheng RK, Dent SF, Liu J, Lopez-Fernandez T, Herrmann J, Scherrer-Crosbie M, Lenihan DJ, Hayek SS, Ky B, Deswal A, Barac A, Nohria A, Ganatra S. SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With Diabetes. JACC CardioOncol. e-Pub 2024. PMID: 39801650.
31. Kumar, A, Khadke, S, AlKindi, S, Rajagopalan, S, Nasir, K, Kazi, DS, Ahmad, J, Khan, S, Asnani, AH, Addison, D, Sadler, D, Deswal, A, Barac, A, Guha, A, Liu, JE, Lenihan, DJ, Neilan, TG, Hayek, SS, Hermann, J, Nohria, A, Dani, SS, Ganatra, S. Particulate Matter 2.5 Pollution Impact on Comorbid Cancer and Cardiovascular Disease Mortality in the U.S. JACC: Advances 3(8), 2024. e-Pub 2024. PMID: 39444413.
32. Deswal A, Lu Y, Khalaf S, Iliescu C, Koutroumpakis E, Yusuf SW, Siddiqui BA, Subudhi SK, Deswal A, Palaskas NL. Use of Positron Emission Tomography for The Diagnosis of Immune Checkpoint Inhibitor Myocarditis, 2024.
33. Kumar A, Khadke S, AlKindi S, Rajagopalan S, Nasir K, Kazi D, Ahmad J, Khan S, Asnani A, Addison D, Sadler D, Deswal A, Barac A, Guha A, Liu J, Lenihan D, Neilan TG, Hayek S, Hermann J, Nohria A, Dani SS, Ganatra S. Particulate Matter 2.5 Pollution Impact on Comorbid Cancer and Cardiovascular Disease Mortality in the U.S. JACC Adv 3(8):101106, 2024. e-Pub 2024. PMID: 39444413.
34. Garg M, Creechan P, Sadeghpour A, Abramov D, Dani SS, Ganatra S, Al-Kindi SG, Michos ED, Misra A, Deswal A, Palaskas NL, Virani SS, Nambi V, Minhas AMK. Trends of Cardiovascular Disease Related Mortality in Breast Cancer in the United States From 1999 to 2019. Am J Cardiol 221:110-112, 2024. e-Pub 2024. PMID: 38643926.
35. Siddiqui BA, Palaskas NL, Basu S, Dai Y, He Z, Yadav SS, Allison JP, Sheth RA, Tummala S, Buja M, Bhattacharjee MB, Iliescu C, Rawther-Karedath A, Deswal A, Wang L, Sharma P, Subudhi SK. Molecular pathways and cellular subsets associated with adverse clinical outcomes in overlapping immune-related myocarditis and myositis. Cancer Immunol Res 12(8):964-987, 2024. e-Pub 2024. PMID: 38768394.
36. Palaskas NL, Ali HJ, Koutroumpakis E, Ganatra S, Deswal A. Cardiovascular toxicity of immune therapies for cancer. BMJ, 2024. PMID: 38749554.
37. Ali, A, Caldwell, R, Pina, G, Beinart, N, Jensen, G, Yusuf, SW, Koutroumpakis, E, Hamzeh, IR, Khalaf, SZ, Iliescu, C, Deswal, A, Palaskas, NL. Elevated IL-6 and Tumor Necrosis Factor-α in Immune Checkpoint Inhibitor Myocarditis. Diseases 12(5), 2024. e-Pub 2024. PMID: 38785743.
38. Zaha VG, Bogle C, Deswal A, Langston A, Rotz S, Vasbinder A, Yang E, Okwuosa T, Clinical Cardiology AHACCOTCO, Genomic CO, Medicine P, on Cardiovascular ATC, Nursing S. Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association. Circulation 149(16):E1113-E1127, 2024. PMID: 38465648.
39. Fenioux, C, Abbar, B, Boussouar, S, Bretagne, M, Power, JR, Moslehi, JJ, Gougis, P, Amelin, D, Dechartres, A, Lehmann, LH, Courand, PY, Cautela, J, Alexandre, J, Procureur, A, Rozes, A, Leonard-Louis, S, Qin, J, Akhter, N, Aghel, N, Amidi, K, Anderson, E, Arangalage, D, Aras, M, Asnani, AH, Baldassarre, LA, Barovila, R, Barroso, AS, Bottinor, W, Bouali, A, Cariou, E, Chang, WT, Cheng, RK, Crusz, S, Deswal, A, Dietrich, PY, Dy, GK, Docq, C, Ewer, SM, Fernando, S, Flint, DL, Florido, R, Fukushima, S, Galli, E, Gaughan, EM, Habib, M, Haydon, A, Heinzerling, L, Itzhaki Ben Zadok, O, Issa, N, Palaskas, NL. Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. Nature Medicine 30(3):910, 2024. e-Pub 2024. PMID: 38172633.
40. Ali A, Jewani P, Khalaf S, Bourdillon M, Koutroumpakis E, Charitakis K, Thompson K, Marmagkiolis K, Deswal A, Iliescu C. Navigating P2Y12 inhibition in the labyrinth of cardio-oncology care: cangrelor bridging in patients with cancer. Front Cardiovasc Med 29(11):1337957, 2024. e-Pub 2024. PMID: 38486704.
41. Chen X, Corrigan KL, Mumme RP, Mukai-Sasaki Y, Koutroumpakis E, Palaskas NL, Nguyen CM, Zhao Y, Huang K, Yu C, Xu T, Daniel A, Balter PA, Zhang X, Niedzielski JS, Shete SS, Deswal A, Court LE, Liao Z, Yang J, Deswal A. Deep learning-based automatic segmentation of cardiac substructures for lung cancers. Radiother Oncol, 2024. PMID: 38122850.
42. Deswal A, Maurer MS, Helmke S, Scherrer-Crosbie M, Soltani M, Goyal A, Zareba K, Cheng R, Kirkpatrick JN, Yogeswaran V, Kitano T, Takeuchi M, Fernandes F, Tiemi Hotta V, Campos Vieira ML, Elissamburu P, Ronderos R, Prado A, Koutroumpakis E, Deswal A, Pursnani A, Sarswat N, Addetia K, Mor-Avi V, Asch FM, Slivnick JA, Lang RM. Limitations of Apical Sparing Pattern in Cardiac Amyloidosis: A Multicenter Echocardiographic Study. Eur Heart J Cardiovasc Imaging 25(6):754-761, 2024. e-Pub 2024. PMID: 38243591.
43. Irizarry-Caro JA, Song J, Miller C, Desai S, Going J, Fossas-Espinosa J, Fatakdawala MM, Ali A, Iliescu C, Palaskas N, Deswal A, Koutroumpakis. Evaluation of Midodrine Utilization in Patients with Cancer and Heart Failure. E.Cardiovasc Drugs Ther 39(3):553-562, 2024. e-Pub 2024. PMID: 38224416.
44. Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, Gorenek B, Hess PL, Hlatky M, Hogan G, Ibeh C, Indik JH, Kido K, Kusumoto F, Link MS, Linta KT, Marcus GM, McCarthy PM, Patel N, Patton KK, Perez MV, Piccini JP, Russo AM, Sanders P, Streur MM, Thomas KL, Times S, Tisdale JE, Valente AM, Van Wagoner DR. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 83(1):109-279, 2024. e-Pub 2024. PMID: 38043043.
45. Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, Gorenek B, Hess PL, Hlatky M, Hogan G, Ibeh C, Indik JH, Kido K, Kusumoto F, Link MS, Linta KT, Marcus GM, McCarthy PM, Patel N, Patton KK, Perez MV, Piccini JP, Russo AM, Sanders P, Streur MM, Thomas KL, Times S, Tisdale JE, Valente AM, Van Wagoner DR. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 149(1):E1-E156, 2024. e-Pub 2024. PMID: 38033089.
46. Kandula VA, Smith GL, Rajaram R, Palaskas NL, Deswal A, Nasir K, Ali HR. A Costly Cure: Understanding and Addressing Financial Toxicity in Cardiovascular Disease Health Care Within the Domain of Social Determinants of Health. Methodist DeBakey cardiovascular journal 20(5):15-26, 2024. e-Pub 2024. PMID: 39525372.
47. Koutroumpakis E, Niku A, Black CK, Ali A, Sadaf H, Song J, Palaskas N, Iliescu C, Durand JB, Yusuf SW, Lee HC, Buja LM, Deswal A, Banchs J. Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis. Front Cardiovasc Med 9, 2024. e-Pub 2024. PMID: 36762300.
48. Avula, V, Sharma, G, Kosiborod, M, Vaduganathan, M, Neilan, TG, López-Fernández, T, Dent, S, Baldassarre, LA, Scherrer-Crosbie, M, Barac, A, Liu, JE, Deswal, A, Khadke, S, Yang, EH, Ky, B, Lenihan, DJ, Nohria, A, Dani, SS, Ganatra, S. SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac Dysfunction. JACC: Heart Failure 12(1):67-78, 2024. e-Pub 2024. PMID: 37897456.
49. Ali, A, Jewani, P, Bourdillon, M, Koutroumpakis, E, Khalaf, SZ, Charitakis, K, Thompson, KA, Marmagkiolis, K, Deswal, A, Iliescu, C. Navigating P2Y12 inhibition in the labyrinth of cardio-oncology care. Frontiers in Cardiovascular Medicine 11, 2024. e-Pub 2024. PMID: 38486704.
50. Chen X, Mumme RP, Corrigan KL, Mukai-Sasaki Y, Koutroumpakis E, Palaskas NL, Nguyen CM, Zhao Y, Huang K, Yu C, Xu T, Daniel A, Balter PA, Zhang X, Niedzielski JS, Shete SS, Deswal A, Court LE, Liao Z, Yang J. Deep learning-based automatic segmentation of cardiac substructures for lung cancers. Radiother Oncol 191, 2023. e-Pub 2023. PMID: 38122850.
51. Isselbacher, EM, Preventza, O, Hamilton Black, J, Augoustides, JG, Beck, AW, Bolen, MA, Braverman, AC, Bray, BE, Brown-Zimmerman, MM, Chen, EP, Collins, TJ, DeAnda, A, Fanola, CL, Girardi, L, Hicks, CW, Hui, DS, Schuyler Jones, W, Kalahasti, V, Kim, KM, Milewicz, DM, Oderich, GS, Ogbechie, L, Promes, SB, Ross, EG, Schermerhorn, ML, Singleton Times, S, Tseng, EE, Wang, GJ, Woo, YJ, Faxon, DP, Upchurch, GR, Aday, AW, Azizzadeh, A, Boisen, M, Hawkins, B, Kramer, CM, Luc, JG, MacGillivray, TE, Malaisrie, SC, Osteen, K, Patel, HJ, Patel, PJ, Popescu, WM, Rodriguez, E, Sorber, R, Tsao, PS, Santos Volgman, A, Beckman, JA, Otto, CM, Deswal, A. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease. Journal of Thoracic and Cardiovascular Surgery 166(5):e182-e331, 2023. e-Pub 2023. PMID: 37389507.
52. Teske, AJ, Moudgil, R, López-Fernández, T, Barac, A, Brown, SA, Deswal, A, Neilan, TG, Ganatra, S, Abdel-Qadir, H, Menon, V, Sverdlov, AL, Cheng, RK, Makhoul, S, Ghosh, AK, Szmit, S, Zaha, VG, Addison, D, Zhang, L, Herrmann, J, Chong, JH, Agarwala, V, Iakobishvili, Z, Guerrero, PA, Yang, EH, Leja, M, Akhter, N, Guha, A, Okwuosa, TM, Silva, CC, Collier, P, Decara, JM, Bauer, B, Lenneman, CG, Sadler, D. Global Cardio Oncology Registry (G-COR). Circulation: Cardiovascular Quality and Outcomes 16(10):718-728, 2023. e-Pub 2023. PMID: 37702048.
53. Jain A, Casanova D, Padilla AV, Bojorges AP, Kotla S, Ko KA, K Samanthapudi VS, Chau K, H Nguyen MT, Wen J, Hernandez Gonzalez SL, Rodgers SP, Olmsted-Davis EA, Hamilton DJ, Reyes-Gibby C, Yeung SJ, Cooke JP, Herrmann J, Chini EN, Xu X, Yusuf SW, Yoshimoto M, Lorenzi PL, Hobbs B, Krishnan S, Koutroumpakis E, Palaskas NL, Wang G, Deswal A, Lin SH, Abe J. Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights. Front Cardiovasc Med , 2023. PMID: 37781317.
54. H Nguyen MT, Imanishi M, Li S, Chau K, Banerjee P, Velatooru LR, Ko KA, K Samanthapudi VS, Gi YJ, Lee L, Abe RJ, McBeath E, Deswal A, Lin SH, Palaskas NL, Dantzer R, Fujiwara K, Borchrdt MK, Turcios EB, Olmsted-Davis EA, Kotla S, Cooke JP, Wang G, Abe J, Le N. Endothelial activation and fibrotic changes are impeded by laminar flow-induced CHK1-SENP2 activity through mechanisms distinct from endothelial-to-mesenchymal cell transition. Front Cardiovasc Med 10, 2023. e-Pub 2023. PMID: 37711550.
55. Jeyabal P, Bhagat A, Wang F, Roth M, Livingston JA, Gilchrist SC, Banchs J, Hildebrandt MAT, Chandra J, Deswal A, Koutroumpakis E, Wang J, Daw NC, Honey TA, Kleinerman ES. Circulating microRNAs and cytokines as prognostic biomarkers for doxorubicin-induced cardiac injury and for evaluating the effectiveness of an exercise intervention. Clin Cancer Res 29(21):4430-4440, 2023. e-Pub 2023. PMID: 37651264.
56. Desai AS, Deswal A, McMurray JJV, Pinney SP, Vaduganathan M. Optimizing Background Therapy for Heart Failure in Clinical Trials: Towards a More Objective Approach. JACC Heart Fail 11(7):806-809, 2023. e-Pub 2023. PMID: 37407155.
57. Members WC, Isselbacher EM, Preventza O, Hamilton Black J, Augoustides JG, Beck AW, Bolen MA, Braverman AC, Bray BE, Brown-Zimmerman MM, Chen EP, Collins TJ, DeAnda A, Fanola CL, Girardi LN, Hicks CW, Hui DS, Schuyler Jones W, Kalahasti V, Kim KM, Milewicz DM, Oderich GS, Ogbechie L, Promes SB, Ross EG, Schermerhorn ML, Singleton Times S, Tseng EE, Wang GJ, Woo YJ, Committee Members PR, Faxon DP, Upchurch GR, Aday AW, Azizzadeh A, Boisen M, Hawkins B, Kramer CM, Luc JGY, MacGillivray TE, Malaisrie SC, Osteen K, Patel HJ, Patel PJ, Popescu WM, Rodriguez E, Sorber R, Tsao PS, Santos Volgman A, Committee Members AJ, Beckman JA, Otto CM, O'Gara PT, Armbruster A, Birtcher KK, de Las Fuentes L, Deswal A, Dixon DL, Gorenek B, Haynes N, Hernandez AF, Joglar JA, Jones WS, Mark D, Mukherjee D, Palaniappan L, Piano MR, Rab T, Spatz ES, Tamis-Holland JE, Woo YJ. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg, 2023. e-Pub 2023. PMID: 37389507.
58. Banerjee P, Rosales JE, Chau K, Nguyen MTH, Kotla S, Lin SH, Deswal A, Dantzer R, Olmsted-Davis EA, Nguyen H, Wang G, Cooke JP, Abe JI, Le NT. Possible molecular mechanisms underlying the development of atherosclerosis in cancer survivors. Front Cardiovasc Med, 2023. e-Pub 2023. PMID: 37332576.
59. Abe JI, Imanishi M, Li S, Zhang A, Ko KA, Samanthapudi VSK, Lee LL, Bojorges AP, Gi YJ, Hobbs BP, Deswal A, Herrmann J, Lin SH, Chini EN, Shen YH, Schadler KL, Nguyen TH, Gupte AA, Reyes-Gibby C, Yeung SJ, Abe RJ, Olmsted-Davis EA, Krishnan S, Dantzer R, Palaskas NL, Cooke JP, Pownall HJ, Yoshimoto M, Fujiwara K, Hamilton DJ, Burks JK, Wang G, Le NT, Kotla S. An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and Atherosclerosis. Circ Res 133(1):25-44, 2023. e-Pub 2023. PMID: 37264926.
60. Kittleson MM, Panjrath GS, Amancherla K, Davis LL, Deswal A, Dixon DL, Jr JJ, Yancy CW. 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 81((18)):1835-1878, 2023. e-Pub 2023. PMID: 37137593.
61. Potter, A, Hulsurkar, MM, Wu, L, Narasimhan, B, Karimzad, K, Koutroumpakis, E, Palaskas, NL, Deswal, A, Kantharia, BK, Wehrens, XH. Kinase Inhibitors and Atrial Fibrillation: Mechanisms of Action and Clinical Implications. JACC: Clinical Electrophysiology 9(4):591-602, 2023. e-Pub 2023. PMID: 37100538.
62. Bernhardt AM, Copeland H, Deswal A, Gluck J, Givertz MM. The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support. J Card Fail 42(4):e1-e64, 2023. e-Pub 2023. PMID: 36754750.
63. Bernhardt AM, Copeland H, Deswal A, Gluck J, Givertz MM. The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support. J Heart Lung Transplant:1053-2498, 2023. e-Pub 2023. PMID: 36805198.
64. Khan S, Dani SS, Hermann J, Neilan TG, Lenihan DJ, Fradley M, Parikh R, Khan S, Deswal A, Liu J, Barac A, Labib S, Majithia A, Nohria A, Baron SJ, Ganatra S. Safety and efficacy of transcatheter edge-to-edge repair (TEER) in patients with history of cancer. Int J Cardiol Heart Vasc 44:101165, 2023. e-Pub 2023. PMID: 36820391.
65. Batchelor WB, Anwaruddin S, Wang DD, Perpetua EM, Krishnaswami A, Velagapudi P, Wyman JF, Fullerton D, Keegan P, Phillips A, Ross L, Maini B, Bernacki G, Panjrath GS, Lee J, Geske JB, Welt F, Thakker PD, Deswal A, Park K, Mack MJ, Leon M, Lewis S, Holmes D. The Multidisciplinary Heart Team in Cardiovascular Medicine: Current Role and Future Challenges. JACC Adv, 2023. e-Pub 2023. PMID: 38939019.
66. Jain, A, Casanova, D, Padilla, AV, Paniagua Bojorges, A, Kotla, S, Ko, KA, Samanthapudi, VS, Chau, KM, Nguyen, MT, Wen, J, Hernandez Gonzalez, SL, Rodgers, SP, Olmsted-Davis, EA, Hamilton, DJ, Reyes-Gibby, CC, Yeung, SJ, Cooke, J, Herrmann, J, Chini, EN, Xu, X, Yusuf, SW, Yoshimoto, M, Lorenzi, PL, Hobbs, BP, Krishnan, S, Koutroumpakis, E, Palaskas, NL, Wang, G, Deswal, A, Lin, SH, Abe, J, Le, NT. Premature senescence and cardiovascular disease following cancer treatments. Frontiers in Cardiovascular Medicine 10, 2023. e-Pub 2023. PMID: 37781317.
67. Honan KA, Hassan S, Deswal A, Herrmann J, Song J, Monlezun D, Halperin D, Mahvash A, Dasari A, Koutroumpakis E, Akay M, Balanescu DV, de Armas IS, Patel M, Nathan S, Kar B, Marmagkiolis K, Lopez-Mattei J, Patel J, Gregoric I, Yao J, Iliescu CA. Bioprosthetic valve monitoring in patients with carcinoid heart disease. Front Cardiovasc Med, 2023. e-Pub 2023. PMID: 36712267.
68. Banerjee, P, Rosales, JE, Chau, KM, Nguyen, MT, Kotla, S, Lin, SH, Deswal, A, Dantzer, R, Olmsted-Davis, EA, Nguyen, H, Wang, G, Cooke, J, Abe, J, Le, NT. Possible molecular mechanisms underlying the development of atherosclerosis in cancer survivors. Frontiers in Cardiovascular Medicine 10, 2023. e-Pub 2023. PMID: 37332576.
69. Batchelor, WB, Anwaruddin, S, Wang, D, Perpetua, EM, Krishnaswami, A, Velagapudi, P, Wyman, JF, Fullerton, D, Keegan, P, Phillips, A, Ross, L, Maini, B, Bernacki, G, Panjrath, GS, Lee, J, Geske, JB, Welt, F, Thakker, PD, Deswal, A, Park, K, Mack, M, Leon, M, Lewis, SZ, Holmes, DR. The Multidisciplinary Heart Team in Cardiovascular Medicine. JACC: Advances 2(1), 2023. e-Pub 2023. PMID: 38939019.
70. Baldassarre LA, Ganatra S, Lopez-Mattei J, Yang EH, Zaha VG, Wong TC, Ayoub C, DeCara JM, Dent S, Deswal A, Ghosh AK, Henry M, Khemka A, Leja M, Rudski L, Villarraga HR, Liu JE, Barac A, Scherrer-Crosbie M, ACC Cardio-Oncology and the ACC Imaging Councils ACC. Advances in Multimodality Imaging in Cardio-Oncology: JACC State-of-the-Art Review. J Am Coll Cardiol 80(16):1560-1578, 2022. e-Pub 2022. PMID: 36229093.
71. Potter AS, Patel A, Khawaja M, Chen C, Zheng H, Kaczmarek J, Gao F, Karimzad K, Song J, Koutroumpakis E, Khalaf S, Iliescu C, Deswal A, Palaskas NL. Outcomes by Class of Anticoagulant Use for Nonvalvular Atrial Fibrillation in Patients With Active Cancer. JACC CardioOncol 4(3):341-350, 2022. e-Pub 2022. PMID: 36213361.
72. Ganatra S, Dani SS, Kumar A, Khan SU, Wadhera R, Neilan TG, Thavendiranathan P, Barac A, Hermann J, Leja M, Deswal A, Fradley M, Liu JE, Sadler D, Asnani A, Baldassarre LA, Gupta D, Yang E, Guha A, Brown SA, Stevens J, Hayek SS, Porter C, Kalra A, Baron SJ, Ky B, Virani SS, Kazi D, Nasir K, Nohria A. Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United States. JACC CardioOncol 4(3):326-337, 2022. e-Pub 2022. PMID: 36213357.
73. Nowatzke J, Guedeney P, Palaskas N, Lehmann L, Ederhy S, Zhu H, Cautela J, Francis S, Courand PY, Deswal A, Ewer SM, Aras M, Arangalage D, Ghafourian K, Fenioux C, Finke D, Peretto G, Zaha V, Itzhaki Ben Zadok O, Tajiri K, Akhter N, Levenson J, Baldassarre L, Power J, Huang S, Collet JP, Moslehi J, registry contributors SJII. Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry. Eur J Cancer 177:197-205, 2022. e-Pub 2022. PMID: 36030143.
74. Manohar H, Potter AS, Koutroumpakis E, Deswal A, Palaskas NL. Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer?. Curr Atheroscler Rep 24(8):599-606, 2022. e-Pub 2022. PMID: 35624391.
75. Koutroumpakis E, Agrawal N, Palaskas NL, Abe J, Iliescu C, Yusuf SW, Deswal A. Myocardial Dysfunction in Patients with Cancer. Heart Fail Clin 18(3):361-374, 2022. e-Pub 2022. PMID: 35718412.
76. Nair A, Deswal A. COVID-19-Associated Fulminant Myocarditis: Pathophysiology-Related Phenotypic Variance. J Am Coll Cardiol 80(4):313-315, 2022. e-Pub 2022. PMID: 35863847.
77. Steiner RE, Banchs J, Koutroumpakis E, Becnel M, Gutierrez C, Strati P, Pinnix CC, Feng L, Rondon G, Claussen C, Palaskas N, Karimzad K, Ahmed S, Neelapu SS, Shpall E, Wang M, Vega F, Westin J, Nastoupil LJ, Deswal A. Cardiovascular events in patients treated with chimeric antigen receptor t-cell therapy for aggressive B-cell lymphoma. Haematologica 107(7):1555-1566, 2022. e-Pub 2021. PMID: 34758610.
78. Bruera S, Lei X, Blau B, Zhao H, Deswal A, Yazdany J, Giordano SH, Suarez-Almazor ME. Postoperative Major Adverse Cardiac Events in Patients With Systemic Lupus Erythematosus. ACR Open Rheumatol 4(6):511-519, 2022. e-Pub 2022. PMID: 35294107.
79. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79(17):e263-e421, 2022. e-Pub 2022. PMID: 35379503.
80. Heidenreich, PA, Bozkurt, B, Aguilar, D, Allen, LA, Byun, JJ, Colvin, MM, Deswal, A, Drazner, MH, Dunlay, SM, Evers, LR, Fang, JC, Fedson, SE, Fonarow, GC, Hayek, SS, Hernandez, AF, Khazanie, P, Kittleson, M, Lee, CS, Link, MS, Milano, CA, Nnacheta, LC, Sandhu, AT, Stevenson, LW, Vardeny, O, Vest, AR, Yancy, CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation 145(18):E876-E894, 2022. e-Pub 2022. PMID: 35363500.
81. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145(18):E895-E1032, 2022. e-Pub 2022. PMID: 35363499.
82. Koutroumpakis E, Deswal A, Yusuf SW, Abe JI, Nead KT, Potter AS, Liao Z, Lin SH, Palaskas NL. Radiation-Induced Cardiovascular Disease Mechanisms, Prevention, and Treatment. Curr Oncol Rep 24(5):543-553, 2022. e-Pub 2022. PMID: 35192118.
83. Power JR, Alexandre J, Choudhary A, Ozbay B, Hayek SS, Asnani A, Tamura Y, Aras M, Cautela J, Thuny F, Gilstrap L, Arangalage D, Ewer S, Huang S, Deswal A, Palaskas NL, Finke D, Lehmann LH, Ederhy S, Moslehi J, Salem JE, Registry II. Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis. Arch Cardiovasc Dis 115(5):315-330, 2022. e-Pub 2022. PMID: 35595646.
84. Ahmed T, Mouhayar E, Song J, Koutroumpakis E, Palaskas NL, Yusuf SW, Lopez-Mattei J, Hassan SA, Kim P, Cilingiroglu M, Marmagkiolis K, Vaporciyan AA, Swisher S, Deswal A, Iliescu C. Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis. Front Cardiovasc Med 9, 2022. e-Pub 2022. PMID: 35711368.
85. Power JR, Alexandre J, Choudhary A, Ozbay B, Hayek SS, Asnani A, Tamura Y, Aras M, Cautela J, Thuny F, Gilstrap L, Arangalage D, Ewer S, Huang S, Deswal A, Palaskas NL, Finke D, Lehmann LH, Ederhy S, Moslehi J, Patel M. Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis. Archives of Cardiovascular Diseases. Volume 115, Issue 5, May 2022, Pages 315-330, 2022. e-Pub 2022.
86. Koutroumpakis E, Deswal A, Yusuf SW, Abe J, Nead KT, Potter AS, Liao Z, Lin SH, Palaskas NL. Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment, 2022. PMID: 35192118.
87. . 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Card Fail 28(5):e1-e167, 2022. e-Pub 2022. PMID: 35378257.
88. Banerjee P, Olmsted-Davis EA, Deswal A, Nguyen MT, Koutroumpakis E, Palaskas NL, Lin SH, Kotla S, Reyes-Gibby C, Yeung SJ, Yusuf SW, Yoshimoto M, Kobayashi M, Yu B, Schadler K, Herrmann J, Cooke JP, Jain A, Chini E, Le NT. Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications. Journal of Cardiovascular Aging 2(3), 2022. e-Pub 2022. PMID: 35801078.
89. Nowakowska MK, Kim T, Thompson MT, Bolton KL, Deswal A, Lin SH, Scheet P, Wehner MR, Nead KT. Association of clonal hematopoiesis mutations with clinical outcomes: a systematic review and meta-analysis. Am J Hematol 97(4):411-420, 2022. e-Pub 2022. PMID: 35015316.
90. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2022. e-Pub 2022. PMID: 35379504.
91. Wang X, Palaskas NL, Hobbs BP, Abe JI, Nead KT, Yusuf SW, Hermann J, Deswal A, Lin SH. The Impact of Radiation Dose to Heart Substructures on Major Coronary Events and Patient Survival after Chemoradiation Therapy for Esophageal Cancer. Cancers (Basel) 14(5), 2022. e-Pub 2022. PMID: 35267613.
92. Heidenreich PA, BozkurtChair B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Card Fail 28(5):810-830, 2022. e-Pub 2022. PMID: 35378259.
93. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79(17):1757-1780, 2022. e-Pub 2022. PMID: 35379504.
94. Imanishi M, Cheng H, Kotla S, Deswal A, Le NT, Chini E, Ko KA, Samanthapudi VSK, Lee LL, Herrmann J, Xu X, Reyes-Gibby C, Yeung SJ, Schadler KL, Yusuf SW, Liao Z, Nurieva R, Amir ED, Burks JK, Palaskas NL, Cooke JP, Lin SH, Kobayashi M, Yoshimoto M, Abe JI. Radiation therapy induces immunosenescence mediated by p90RSK. Front Cardiovasc Med 9:988713, 2022. e-Pub 2022. PMID: 36426217.
95. Honan KA, Hassan S, Deswal A, Herrmann J, Song J, Monlezun D, Halperin D, Mahvash A, Dasari A, Koutroumpakis E, Akay M, Balanescu DV, de Armas IS, Patel M, Nathan S, Kar B, Marmagkiolis K, Lopez-Mattei J, Patel J, Gregoric I, Yao J, Iliescu CA. Bioprosthetic valve monitoring in patients with carcinoid heart disease. Front Cardiovasc Med 9:1072890, 2022. e-Pub 2022. PMID: 36712267.
96. Verma, S, Dhingra, NK, Butler, J, Anker, SD, Ferreira, JP, Filippatos, G, Januzzi, JL, Lam, CS, Sattar, N, Peil, B, Nordaby, M, Brueckmann, M, Pocock, SJ, Zannad, F, Packer, M, Packer, M, Butler, J, Pocock, S, Zannad, F, Ferreira, JP, Brueckmann, M, George, J, Jamal, W, Welty, FK, Palmer, M, Clayton, T, Parhofer, KG, Pedersen, TR, Greenberg, B, Konstam, MA, Lees, KR, Carson, P, Doehner, W, Miller, A, Haas, M, Pehrson, S, Komajda, M, Anand, I, Teerlink, J, Rabinstein, AA, Steiner, T, Kamel, H, Tsivgoulis, G, Lewis, JH, Freston, JW, Kaplowitz, N, Mann, J, Petrie, J, Perrone, S, Deswal, A. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced). The Lancet Diabetes and Endocrinology 10(1):35-45, 2022. e-Pub 2022. PMID: 34861154.
97. Koutroumpakis E, Xu T, Lopez-Mattei J, Pan T, Lu Y, Irizarry-Caro JA, Mohan R, Zhang X, Meng QH, Lin R, Xu T, Deswal A, Liao Z. Coronary artery calcium score on standard of care oncologic CT scans for the prediction of adverse cardiovascular events in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy. Front Cardiovasc Med 9:1071701, 2022. e-Pub 2022. PMID: 36531700.
98. Batra A, Patel B, Addison D, Baldassarre LA, Desai N, Weintraub N, Deswal A, Hussain Z, Brown SA, Ganatra S, Agarwala V, Parikh PM, Fradley M, Ghosh A, Guha A. Cardiovascular Safety Profile of Taxanes and Vinca Alkaloids: 30 years FDA Registry Experience. Open Heart 8(2), 2021. e-Pub 2021. PMID: 34952868.
99. Power JR, Alexandre J, Choudhary A, Ozbay B, Hayek S, Asnani A, Tamura Y, Aras M, Cautela J, Thuny F, Gilstrap L, Arangalage D, Ewer S, Huang S, Deswal A, Palaskas NL, Finke D, Lehman L, Ederhy S, Moslehi J, Salem JE, Registry† II. Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis. Circulation 144(18):1521-1523, 2021. e-Pub 2021. PMID: 34723640.
100. Kotla S, Zhang A, Imanishi M, Ko KA, Lin SH, Gi YJ, Moczygemba M, Isgandarova S, Schadler KL, Chung C, Milgrom SA, Banchs J, Yusuf SW, Amaya DN, Guo H, Thomas TN, Shen YH, Deswal A, Herrmann J, Kleinerman ES, Entman ML, Cooke JP, Schifitto G, Maggirwar SB, McBeath E, Gupte AA, Krishnan S, Patel ZS, Yoon Y, Burks JK, Fujiwara K, Brookes PS, Le NT, Hamilton DJ, Abe JI. Nucleus-mitochondria positive feedback loop formed by ERK5 S496 phosphorylation-mediated poly (ADP-ribose) polymerase activation provokes persistent pro-inflammatory senescent phenotype and accelerates coronary atherosclerosis after chemo-radiation. Redox Biol 47:102132, 2021. e-Pub 2021. PMID: 34619528.
101. Lehmann LH, Cautela J, Palaskas N, Baik AH, Meijers WC, Allenbach Y, Alexandre J, Rassaf T, Müller OJ, Aras M, Asnani AH, Deswal A, Laufer-Perl M, Thuny F, Kerneis M, Hayek SS, Ederhy S, Salem JE, Moslehi JJ. Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative Review. JAMA Cardiol 6(11):1329-1337, 2021. e-Pub 2021. PMID: 34232253.
102. Palaskas NL, Segura A, Lelenwa L, Siddiqui BA, Subudhi SK, Lopez-Mattei J, Durand JB, Deswal A, Zhao B, Maximilian Buja L, Iliescu C. Immune Checkpoint Inhibitor Myocarditis: Elucidating the spectrum of disease through endomyocardial biopsy. Eur J Heart Fail 23(10):1725-1735, 2021. e-Pub 2021. PMID: 34114291.
103. Members WC, Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O'Gara PT, Rigolin VH, Sundt TM, Thompson A, Toly C, Committee Members AJ, O'Gara PT, Beckman JA, Levine GN, Al-Khatib SM, Armbruster A, Birtcher KK, Ciggaroa J, Deswal A, Dixon DL, Fleisher LA, de Las Fuentes L, Gentile F, Goldberger ZD, Gorenek B, Haynes N, Hernandez AF, Hlatky MA, Joglar JA, Jones WS, Marine JE, Mark D, Palaniappan L, Piano MR, Spatz ES, Tamis-Holland J, Wijeysundera DN, Woo YJ. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg 162(2):e183-e353, 2021. e-Pub 2021. PMID: 33972115.
104. Goel H, Hirsch JR, Deswal A, Hassan SA. Anemia in Cardiovascular Disease: Marker of Disease Severity or Disease-modifying Therapeutic Target?. Curr Atheroscler Rep 23(10):61, 2021. e-Pub 2021. PMID: 34374878.
105. Koutroumpakis E, Kaur R, Taegtmeyer H, Deswal A. Obesity and Heart Failure with Preserved Ejection Fraction. Heart Fail Clin 17(3):345-356, 2021. e-Pub 2021. PMID: 34051967.
106. Members WC, Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P, Committee Members AJ, O'Gara PT, Beckman JA, Levine GN, Al-Khatib SM, Armbruster A, Birtcher KK, Ciggaroa J, Dixon DL, de Las Fuentes L, Deswal A, Fleisher LA, Gentile F, Goldberger ZD, Gorenek B, Haynes N, Hernandez AF, Hlatky MA, Joglar JA, Jones WS, Marine JE, Mark D, Palaniappan L, Piano MR, Tamis-Holland J, Wijeysundera DN, Woo YJ. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg 162(1):e23-e106, 2021. e-Pub 2021. PMID: 33926766.
107. Challa, AA, Calaway, AC, Cullen, J, Garcia, JA, Desai, NR, Weintraub, NL, Deswal, A, Kutty, S, Vallakati, A, Addison, D, Baliga, R, Campbell, CM, Guha, A. Cardiovascular Toxicities of Androgen Deprivation Therapy. Current treatment options in oncology 22(6), 2021. e-Pub 2021. PMID: 33866442.
108. Baldassarre LA, Yang EH, Cheng RK, DeCara JM, Dent S, Liu JE, Rudski LG, Strom JB, Thavendiranathan P, Barac A, Zaha VG, Bucciarelli-Ducci C, Ellahham S, Deswal A, Lenneman C, Villarraga HR, Blaes AH, Ismail-Khan R, Ky B, Leja MJ, Scherrer-Crosbie M. Cardiovascular care of the oncology patient during COVID-19: An expert consensus document from the ACC Cardio-Oncology and Imaging Councils. J Natl Cancer Inst 113(5):513-522, 2021. e-Pub 2021. PMID: 33179744.
109. Aldrich J, Pundole X, Tummala S, Palaskas N, Andersen CR, Shoukier M, Abdel-Wahab N, Deswal A, Suarez-Almazor ME. Inflammatory myositis in cancer patients receiving immune checkpoint inhibitors. Arthritis Rheumatol 73(5):866-874, 2021. e-Pub 2021. PMID: 33258544.
110. Cunningham LC, Fonarow GC, Yancy CW, Sheng S, Matsouaka RA, DeVore AD, Jneid H, Deswal A. Regional Variations in Heart Failure Quality and Outcomes: Get With The Guidelines-Heart Failure Registry. J Am Heart Assoc 10(7):e018696, 2021. e-Pub 2021. PMID: 33759546.
111. Hussain A, Sun W, Deswal A, de Lemos JA, McEvoy JW, Hoogeveen RC, Matsushita K, Aguilar D, Bozkurt B, Virani SS, Shah AM, Selvin E, Ndumule C, Ballantyne CM, Nambi V. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study. J Am Coll Cardiol 77(5):559-571, 2021. e-Pub 2021. PMID: 33538254.
112. Heidari-Bateni G, Durand JB, Iliescu C, Gladish G, Deswal A, Patel AR, Kim P, Song J, Hassan S, Palaskas N, Baldassarre LA, Bucciarelli-Ducci C, Lopez-Mattei J. Clinical Impact of Cardiovascular Magnetic Resonance in Cancer Patients With Suspected Cardiomyopathy. Front Cardiovasc Med 8:734820, 2021. e-Pub 2021. PMID: 34765654.
113. Banerjee P, Kotla S, Reddy Velatooru L, Abe RJ, Davis EA, Cooke JP, Schadler K, Deswal A, Herrmann J, Lin SH, Abe JI, Le NT. Senescence-Associated Secretory Phenotype as a Hinge Between Cardiovascular Diseases and Cancer. Front Cardiovasc Med 8:763930, 2021. e-Pub 2021. PMID: 34746270.
114. Koutroumpakis E, Hashmi SS, Powell C, Fatakdawala M, Pang J, Patel R, Thannoun T, Grable C, Damaraju S, Badruddin Mawji S, Lin K, Folivi M, Chauhan S, Shabbir MA, Hughes K, Peters TK, Lyubarova R, Damaraju S, Palaskas N, Deswal A, Garcia-Sayan E, Taegtmeyer H. Geographical Differences in Cardiovascular Comorbidities and Outcomes of COVID-19 Hospitalized Patients in the USA. Cardiology 26(4):1-8, 2021. e-Pub 2021. PMID: 33902039.
115. Bravo-Jaimes K, Palaskas NL, Banchs J, Abelhad NI, Altaf A, Gouni S, Song J, Hassan SA, Iliescu C, Deswal A, Yusuf SW. Rate of Progression of Aortic Stenosis in Patients With Cancer. Front Cardiovasc Med 8:644264, 2021. e-Pub 2021. PMID: 33816575.
116. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 76(25):3022-3055, 2020. e-Pub 2020. PMID: 33229115.
117. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 142(25):e558-e631, 2020. e-Pub 2020. PMID: 33215931.
118. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 76(25):e159-e240, 2020. e-Pub 2020. PMID: 33229116.
119. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 142(25):e533-e557, 2020. e-Pub 2020. PMID: 33215938.
120. Sterling MR, Kern LM, Safford MM, Jones CD, Feldman PH, Fonarow GC, Sheng S, Matsouaka RA, DeVore AD, Lytle B, Xu H, Allen LA, Deswal A, Yancy CW, Albert NM. Home Health Care Use and Post-Discharge Outcomes After Heart Failure Hospitalizations. JACC Heart Fail 8(12):1038-1049, 2020. e-Pub 2020. PMID: 32800510.
121. Jacob R, Strati P, Palaskas N, Lopez-Mattei JC, Marmagkiolis K, Buja LM, Deswal A, Iliescu C. Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy. JACC Case Rep 2(13):2095-2100, 2020. e-Pub 2020. PMID: 34317115.
122. Sharma K, Mok Y, Kwak L, Agarwal SK, Chang PP, Deswal A, Shah AM, Kitzman DW, Wruck LM, Loehr LR, Heiss G, Coresh J, Rosamond WD, Solomon SD, Matsushita K, Russell SD. Predictors of Mortality by Sex and Race in Heart Failure With Preserved Ejection Fraction: ARIC Community Surveillance Study. J Am Heart Assoc 9(19):e014669, 2020. e-Pub 2020. PMID: 32924735.
123. Palaskas NL, Koutroumpakis E, Deswal A. COVID-19 and Cardiovascular Health Among Patients with Cancer. Curr Cardiol Rep 22(12):171, 2020. e-Pub 2020. PMID: 33040241.
124. Wang X, Palaskas NL, Yusuf SW, Abe JI, Lopez-Mattei J, Banchs J, Gladish GW, Lee P, Liao Z, Deswal A, Lin SH. Incidence and Onset of Severe Cardiac Events After Radiotherapy for Esophageal Cancer. J Thorac Oncol 15(10):1682-1690, 2020. e-Pub 2020. PMID: 32599073.
125. Balanescu DV, Donisan T, Deswal A, Palaskas N, Song J, Lopez-Mattei J, Kim PY, Durand JB, Doundoua D, Marmagkiolis K, Iliescu C. Acute myocardial infarction in a high-risk cancer population: Outcomes following conservative versus invasive management. Int J Cardiol 313:1-8, 2020. e-Pub 2020. PMID: 32320781.
126. Simbaqueba Clavijo, CA, Aponte, MP, Kim, P, Deswal, A, Palaskas, NL, Iliescu, C, Jahangir, E, Yang, EH, Steiner, RE, Lopez-Mattei, J. Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy: The Cytokine Release Syndrome and Associated Arrhythmias. Journal of Immunotherapy and Precision Oncology 3(3):113-120, 2020. e-Pub 2020. PMID: 35663258.
127. Mandviwala TM, Basra SS, Khalid U, Pickett JK, Przybylowicz R, Shah T, Nambi V, Virani SS, Deswal A. Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction. Int J Obes (Lond) 44(7):1561-1567, 2020. e-Pub 2020. PMID: 32483205.
128. Safdar Z, Frost A, Basant A, Deswal A, O'Brian Smith E, Entman M. Spironolactone in pulmonary arterial hypertension: results of a cross-over study. Pulm Circ 10(2):2045894019898030, 2020. e-Pub 2020. PMID: 32426108.
129. Stehlik J, Schmalfuss C, Bozkurt B, Nativi-Nicolau J, Wohlfahrt P, Wegerich S, Rose K, Ray R, Schofield R, Deswal A, Sekaric J, Anand S, Richards D, Hanson H, Pipke M, Pham M. Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study. Circ Heart Fail 13(3):e006513, 2020. e-Pub 2020. PMID: 32093506.
130. Koutroumpakis E, Palaskas NL, Lin SH, Abe JI, Liao Z, Banchs J, Deswal A, Yusuf SW. Modern Radiotherapy and Risk of Cardiotoxicity. Chemotherapy 13(3-4):1-12, 2020. e-Pub 2020. PMID: 33049738.
131. Palaskas N, Lopez-Mattei J, Durand JB, Iliescu C, Deswal A. Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment. J Am Heart Assoc 9(2):e013757, 2020. e-Pub 2020. PMID: 31960755.
132. Fadol AP, Palaskas NL, Ewer MS, Deswal A. An overview of a different type of cardio-oncology gathering: summary of the COMP (cardio-oncology multidisciplinary practice) meeting held in Houston Texas, January 2020. Cardiooncology 15(6):20, 2020. e-Pub 2020. PMID: 32944289.
133. Walther CP, Winkelmayer WC, Deswal A, Niu J, Navaneethan SD. Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization. Am J Nephrol 51(3):1-10, 2020. e-Pub 2020. PMID: 31962311.
134. Walther CP, Winkelmayer WC, Niu J, Cheema FH, Nair AP, Morgan JA, Fedson SE, Deswal A, Navaneethan SD. Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes. Am J Kidney Dis 74(5):650-658, 2019. e-Pub 2019. PMID: 31160142.
135. Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, Deswal A, Dickson VV, Kosiborod MN, Lekavich CL, McCoy RG, Mentz RJ, Piña IL, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement from the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation 140(7):e294-e324, 2019. e-Pub 2019. PMID: 31167558.
136. Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, Deswal A, Dickson VV, Kosiborod MN, Lekavich CL, McCoy RG, Mentz RJ, PiÑa IL, Clinical Cardiology AHAHFATCOTCO, Stroke Nursing COCA, HFSA. Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America. J Card Fail 25(8):584-619, 2019. e-Pub 2019. PMID: 31174952.
137. Trang A, Kampangkaew J, Fernandes R, Tiwana J, Misra A, Hamzeh I, Blaustein A, Aguilar D, Shah T, Ballantyne C, Quinones M, Nagueh SF, Dokanish H, Virani SS, Deswal A, Kirkpatrick JN, Nambi V. Understanding by General Providers of the Echocardiogram Report. Am J Cardiol 124(2):296-302, 2019. e-Pub 2019. PMID: 31104774.
138. House AA, Wanner C, Sarnak MJ, Piña IL, McIntyre CW, Komenda P, Kasiske BL, Deswal A, deFilippi CR, Cleland JGF, Anker SD, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, McCullough PA, Participants C. Heart Failure in Chronic Kidney Disease: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 95(6):1304-1317, 2019. e-Pub 2019. PMID: 31053387.
139. Vest AR, Chan M, Deswal A, Givertz MM, Lekavich C, Lennie T, Litwin SE, Parsly L, Rodgers JE, Rich MW, Schulze PC, Slader A, Desai A. Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee. J Card Fail 25(5):380-400, 2019. e-Pub 2019. PMID: 30877038.
140. Levine GN, O'Gara PT, Beckman JA, Al-Khatib SM, Birtcher KK, Cigarroa JE, de Las Fuentes L, Deswal A, Fleisher LA, Gentile F, Goldberger ZD, Hlatky MA, Joglar JA, Piano MR, Wijeysundera DN. Recent Innovations, Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 73(15):1990-1998, 2019. e-Pub 2019. PMID: 30904245.
141. Levine GN, O'Gara PT, Beckman JA, Al-Khatib SM, Birtcher KK, Cigarroa JE, de Las Fuentes L, Deswal A, Fleisher LA, Gentile F, Goldberger ZD, Hlatky MA, Joglar JA, Piano MR, Wijeysundera DN. Recent Innovations, Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139(17):e879-e886, 2019. e-Pub 2019. PMID: 30892927.
142. Stout, KK, Daniels, CJ, Aboulhosn, JA, Bozkurt, B, Broberg, CS, Colman, JM, Crumb, SR, Dearani, JA, Fuller, S, Gurvitz, M, Khairy, P, Landzberg, MJ, Saidi, A, Valente, AM, Van Hare, GF, Levine, GN, Ogara, PT, Halperin, JL, Albert, NM, Al-Khatib, SM, Beckman, JA, Birtcher, KK, Bozkurt, B, Brindis, RG, Cigarroa, JE, Curtis, LH, Deswal, A, Fleisher, L, Gentile, F, Gidding, S, Goldberger, ZD, Hlatky, MA, Ikonomidis, JS, Joglar, JA, Kovacs, RJ, Mauri, L, Ohman, EM, Piano, MR, Pressler, SJ, Riegel, B, Sellke, FW, Shen, WK, Wijeysundera, DN, Michael Valentine, C, Gates, CC, Oetgen, WJ, Elma, MA, Scholtz, A, Sheehan, KA, Abdullah, AR. 2018 AHA/ACC guideline for the management of adults with congenital heart disease. Circulation 139(14):E637-E697, 2019. e-Pub 2019. PMID: 30586768.
143. Hira RS, Kataruka A, Akeroyd JM, Ramsey DJ, Pokharel Y, Gurm HS, Nasir K, Deswal A, Jneid H, Alam M, Ballantyne CM, Petersen LA, Virani SS. Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes 12(1):e004817, 2019. e-Pub 2019. PMID: 30636483.
144. Walther CP, Winkelmayer WC, Deswal A, Niu J, Navaneethan SD. Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRD. Am J Kidney Dis 72(4):620-622, 2018. e-Pub 2018. PMID: 29784611.
145. Nair A, Deswal A. Aldosterone Receptor Blockade in Heart Failure with Preserved Ejection Fraction. Heart Fail Clin 14(4):525-535, 2018. e-Pub 2018. PMID: 30266361.
146. Lenihan CR, Liu S, Deswal A, Montez-Rath ME, Winkelmayer WC. De Novo Heart Failure after Kidney Transplantation: Trends in Incidence and Outcomes. Am J Kidney Dis 72(2):223-233, 2018. e-Pub 2018. PMID: 29605378.
147. Misra A, Deswal A. NT-proBNP-guided and conventional therapies did not differ for readmission or mortality in acute decompensated HF. Ann Intern Med 169(4):JC21, 2018. e-Pub 2018. PMID: 30128511.
148. Walther CP, Niu J, Winkelmayer WC, Cheema FH, Nair AP, Morgan JA, Fedson SE, Deswal A, Navaneethan SD. Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc 7(14), 2018. e-Pub 2018. PMID: 29980520.
149. Faza NN, Akeroyd JM, Ramsey DJ, Shah T, Nasir K, Deswal A, Ballantyne CM, Petersen LA, Virani SS. Effectiveness of NPs and PAs in managing diabetes and cardiovascular disease. JAAPA 31(7):39-45, 2018. e-Pub 2018. PMID: 29957606.
150. Basra SS, Wang TY, Simon DN, Chiswell K, Virani SS, Alam M, Nambi V, Denktas AE, Deswal A, Bozkurt B, Ballantyne CM, Peterson ED, Jneid H. Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc 7(12), 2018. e-Pub 2018. PMID: 29886424.
151. Saeed A, Nambi V, Sun W, Virani SS, Taffet GE, Deswal A, Selvin E, Matsushita K, Wagenknecht LE, Hoogeveen R, Coresh J, de Lemos JA, Ballantyne CM. Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults. J Am Coll Cardiol 71(22):2527-2536, 2018. e-Pub 2018. PMID: 29535064.
152. Virani SS, Akeroyd JM, Ramsey DJ, Deswal A, Nasir K, Rajan SS, Ballantyne CM, Petersen LA. Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery among Advanced Practice Providers and Physician Providers in Primary Care. Popul Health Manag 21(3):209-216, 2018. e-Pub 2018. PMID: 28994631.
153. Whelton, PK, Carey, RM, Aronow, WS, Casey, DE, Collins, KJ, Himmelfarb, CD, DePalma, SM, Gidding, S, Jamerson, KA, Jones, DW, MacLaughlin, EJ, Muntner, P, Ovbiagele, B, Smith, SC, Spencer, CC, Stafford, RS, Taler, SJ, Thomas, RJ, Williams, KA, Williamson, J, Wright, JT, Levine, GN, Ogara, PT, Halperin, JL, Past, I, Al, SM, Beckman, JA, Birtcher, KK, Bozkurt, B, Brindis, RG, Cigarroa, JE, Curtis, LH, Deswal, A, Fleisher, L, Gentile, F, Goldberger, ZD, Hlatky, MA, Ikonomidis, JS, Joglar, JA, Mauri, L, Pressler, SJ, Riegel, B, Wijeysundera, DN, Walsh, MN, Jacobovitz, S, Oetgen, WJ, Elma, MA, Scholtz, A, Sheehan, KA, Abdullah, AR. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults a report of the American College of Cardiology/American Heart Association Task Force on Clinical practice guidelines. Hypertension 71(6):E13-E115, 2018. e-Pub 2018. PMID: 29133356.
154. Reboussin, DM, Allen, NB, Griswold, M, Guallar, E, Hong, Y, Lackland, DT, Miller, ER, Polonsky, TS, Thompson-Paul, AM, Vupputuri, S, Levine, GN, Ogara, PT, Halperin, JL, Past, I, Al-Khatib, SM, Beckman, JA, Birtcher, KK, Bozkurt, B, Brindis, RG, Cigarroa, JE, Curtis, LH, Deswal, A, Fleisher, L, Gentile, F, Gidding, S, Goldberger, ZD, Hlatky, MA, Ikonomidis, JS, Joglar, JA, Mauri, L, Pressler, SJ, Riegel, B, Wijeysundera, DN, Walsh, MN, Jacobovitz, S, Oetgen, WJ, Elma, MA, Scholtz, A, Sheehan, KA, Abdullah, AR, Tahir, N, Warner, JJ, Brown, N, Robertson, RM, Whitman, GR, Hundley, J. Systematic review for the 2017 ACC/AHA/AAPA/ABC/ ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults a report of the American College of Cardiology/American Heart Association Task Force on Clinical practice guidelines. Hypertension 71(6):E116-E135, 2018. e-Pub 2018. PMID: 30354656.
155. Greet B, Schurmann P, Deswal A. In AF and HF, catheter ablation vs medical therapy reduced mortality and hospitalization for worsening HF. Ann Intern Med 168(10):JC55, 2018. e-Pub 2018. PMID: 29800431.
156. Khalid U, Deswal A. Observation Versus Inpatient Stay for Heart Failure: Is it Semantics?. J Am Heart Assoc 7(3), 2018. e-Pub 2018. PMID: 29386208.
157. Nambi V, Deswal A, Ballantyne CM. Prevention of "Failure": Is It a Failure of Prevention?. Circulation 137(2):106-108, 2018. e-Pub 2018. PMID: 29311345.
158. Saeed A, Nambi V, Sun W, Virani SS, Taffet G, Deswal A, Selvin E, Matsushita K, Wagenknecht LE, Hoogeveen R, Coresh J, de Lemos JA, Ballantyne CM. Do Biomarkers Improve Short-term Risk Prediction of Global Cardiovascular Events in Older Adults? Insights from the Atherosclerosis Risk in Communities Study. Journal of Clinical Lipidology 12:525-526, 2018. e-Pub 2018.
159. Nguyen P, Kamran H, Nasir S, Chan W, Shah T, Deswal A, Bozkurt B. Comparison of Frequency of Cardiovascular Events and Mortality in Patients With Heart Failure Using Versus Not Using Cocaine. Am J Cardiol 119(12):2030-2034, 2017. e-Pub 2017. PMID: 28456314.
160. Khalid U, Wruck LM, Quibrera PM, Bozkurt B, Nambi V, Chang PP, Virani SS, Jneid H, Agarwal S, Loehr L, Basra SS, Rosamond W, Ballantyne CM, Deswal A. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol 233:61-66, 2017. e-Pub 2017. PMID: 28185703.
161. Butler J, Anstrom KJ, Felker GM, al E. Efficacy and Safety of spironolactone in acute heart failure: The ATHENA-HF Randomzied Clinical Trial. JAMA Cardiol 2:950-958, 2017. e-Pub 2017.
162. Pokharel Y, Sun W, Virani SS, Nambi V, Hoogeveen RC, Chang PP, Ndumele CE, Solomon SD, Bozkurt B, Selvin E, Ballantyne CM, Deswal A. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study. JACC Heart Fail 5(1):56-63, 2017. e-Pub 2017. PMID: 28017350.
163. Bozkurt B, Aguilar D, Deswal A, Dunbar SB, Francis GS, Horwich T, Jessup M, Kosiborod M, Pritchett AM, Ramasubbu K, Rosendorff C, Yancy C, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular and Stroke Nursing; Council on Hypertension; and Council on Quality and Outcomes Research. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement from the American Heart Association. Circulation 134(23):e535-e578, 2016. e-Pub 2016. PMID: 27799274.
164. Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, Francis GS, Lenihan D, Lewis EF, McNamara DM, Pahl E, Vasan RS, Ramasubbu K, Rasmusson K, Towbin JA, Yancy C, Outcomes Research AHACOHFATOTCOCCCOCDITYCOCASNCOEAPACOQOCA. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement from the American Heart Association. Circulation 134(23):e579-e646, 2016. e-Pub 2016. PMID: 27832612.
165. Hira RS, Cowart JB, Akeroyd JM, Ramsey DJ, Pokharel Y, Nambi V, Jneid H, Deswal A, Denktas A, Taylor A, Nasir K, Ballantyne CM, Petersen LA, Virani SS. Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. Am J Cardiol 118(8):1144-1149, 2016. e-Pub 2016. PMID: 27553104.
166. Wan SH, Stevens SR, Borlaug BA, Anstrom KJ, Deswal A, Felker GM, Givertz MM, Bart BA, Tang WH, Redfield MM, Chen HH. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure with Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). Circ Heart Fail 9(8), 2016. e-Pub 2016. PMID: 27512103.
167. Shah T, Deswal A. ACP Journal Club. Review: In HF with reduced EF, nurse-led titration of HF drugs reduces hospitalizations and mortality. Ann Intern Med 164(8):JC41, 2016. e-Pub 2016. PMID: 27089090.
168. Pokharel Y, Wei J, Hira RS, Kalra A, Shore S, Kerkar PG, Kumar G, Risch S, Vicera V, Oetgen WJ, Deswal A, Turakhia MP, Glusenkamp N, Virani SS. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program. Clin Cardiol 39(3):145-9, 2016. e-Pub 2016. PMID: 26880649.
169. Ndumele CE, Matsushita K, Sang Y, Lazo M, Agarwal SK, Nambi V, Deswal A, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 133(7):631-8, 2016. e-Pub 2016. PMID: 26746175.
170. Ndumele CE, Matsushita K, Sang Y, Lazo M, Agarwal SK, Nambi V, Deswal A, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E. NT-proBNP and Heart Failure Risk among Individuals With and Without Obesity: The ARIC Study. Circulation 133(7):631-8, 2016. e-Pub 2016.
171. Shah AM, Claggett B, Sweitzer NK, Shah SJ, Deswal A, Anand IS, Fleg JL, Pitt B, Pfeffer MA, Solomon SD. Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone. Circ Heart Fail 8(6):1052-8, 2015. e-Pub 2015. PMID: 26475142.
172. Virani SS, Maddox TM, Chan PS, Tang F, Akeroyd JM, Risch SA, Oetgen WJ, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA. Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights from the NCDR PINNACLE Registry. J Am Coll Cardiol 66(16):1803-1812, 2015. e-Pub 2015. PMID: 26483105.
173. Borlaug BA, Chen H, Lin G, Redfield MM, Lewis GD, Semigran MJ, McNulty SE, LeWinter M, Deswal A, Margulies KB. Response to Letter Regarding Article, “Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction”. Circ Heart Fail 8(4):840, 2015. e-Pub 2015. PMID: 26405727.
174. Givertz MM, Anstrom KJ, Redfield MM, Deswal A, Haddad H, Butler J, Tang WH, Dunlap ME, LeWinter MM, Mann DL, Felker GM, O'Connor CM, Goldsmith SR, Ofili EO, Saltzberg MT, Margulies KB, Cappola TP, Konstam MA, Semigran MJ, McNulty SE, Lee KL, Shah MR, Hernandez AF, Research Network NHFC. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study. Circulation 131(20):1763-71, 2015. e-Pub 2015. PMID: 25986447.
175. Borlaug BA, Lewis GD, McNulty SE, Semigran MJ, LeWinter M, Chen H, Lin G, Deswal A, Margulies KB, Redfield MM. Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction. Circ Heart Fail 8(3):533-41, 2015. e-Pub 2015. PMID: 25782985.
176. Bandeali SJ, Gosch K, Alam M, Kayani WT, Jneid H, Fiocchi F, Wilson JM, Chan PS, Deswal A, Maddox TM, Virani SS. Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE registry). Am J Cardiol 115(8):1013-8, 2015. e-Pub 2015. PMID: 25721483.
177. Gonçalves A, Claggett B, Jhund PS, Rosamond W, Deswal A, Aguilar D, Shah AM, Cheng S, Solomon SD. Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study. Eur Heart J 36(15):939-45, 2015. e-Pub 2015. PMID: 25602025.
178. Albert NM, Barnason S, Deswal A, Hernandez A, Kociol R, Lee E, Paul S, Ryan CJ, White-Williams C, Stroke Nursing AHACCPAFCCOTCOCA, Clinical Cardiology CO, Outcomes Research ACOQOCA. Transitions of Care in Heart Failure: A Scientific Statement from the American Heart Association. Circ Heart Fail 8(2):384-409, 2015. e-Pub 2015. PMID: 25604605.
179. Hira RS, Kennedy K, Nambi V, Jneid H, Alam M, Basra SS, Ho PM, Deswal A, Ballantyne CM, Petersen LA, Virani SS. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. J Am Coll Cardiol 65(2):111-21, 2015. e-Pub 2015. PMID: 25593051.
180. Abraham NS, Naik AD, Shelton G, Street RL, Castillo DL, Deswal A, Richardson PA, Hartman CM, Fraenkel L. Complex antithrombotic therapy: determinants of patient preference and impact on medication adherence. Patient Prefer Adherence 9:1657-68, 2015. e-Pub 2015. PMID: 26640372.
181. Virani SS, Woodard LD, Ramsey DJ, Urech TH, Akeroyd JM, Shah T, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA. Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol 115(1):21-6, 2015. e-Pub 2015. PMID: 25456865.
182. Basra SS, Pokharel Y, Hira RS, Bandeali SJ, Nambi V, Deswal A, Nasir K, Martin SS, Vogel RA, Roberts AJ, Ballantyne CM, Virani SS. Relation between playing position and coronary artery calcium scores in retired National Football League players. Am J Cardiol 114(12):1836-40, 2014. e-Pub 2014. PMID: 25432152.
183. Khalid U, Ather S, Bavishi C, Chan W, Loehr LR, Wruck LM, Rosamond WD, Chang PP, Coresh J, Virani SS, Nambi V, Bozkurt B, Ballantyne CM, Deswal A. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol 64(25):2743-9, 2014. e-Pub 2014. PMID: 25541126.
184. Safdar Z, Tamez E, Chan W, Arya B, Ge Y, Deswal A, Bozkurt B, Frost A, Entman M. Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension. JACC Heart Fail 2(4):412-21, 2014. e-Pub 2014. PMID: 25023820.
185. Kurrelmeyer KM, Ashton Y, Xu J, Nagueh SF, Torre-Amione G, Deswal A. Effects of spironolactone treatment in elderly women with heart failure and preserved left ventricular ejection fraction. J Card Fail 20(8):560-8, 2014. e-Pub 2014. PMID: 24905296.
186. Bavishi C, Ather S, Bambhroliya A, Jneid H, Virani SS, Bozkurt B, Deswal A. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol 113(11):1834-8, 2014. e-Pub 2014. PMID: 24837261.
187. Rogers PA, Daye J, Huang H, Blaustein A, Virani S, Alam M, Kumar A, Paniagua D, Kar B, Bozkurt B, Ballantyne CM, Deswal A, Jneid H. Revascularization improves mortality in elderly patients with acute myocardial infarction complicated by cardiogenic shock. Int J Cardiol 172(1):239-41, 2014. e-Pub 2014. PMID: 24462137.
188. Zakeri R, Borlaug BA, McNulty SE, Mohammed SF, Semigran MJ, Lewis GD, Deswal A, LeWinter M, Hernandez AF, Braunwald E, Redfield MM. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail 7(1):123-30, 2014. e-Pub 2014. PMID: 24162898.
189. Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, LeWinter MM, Bull DA, Stehlik J, Konstam MA, Huggins GS, Rouleau JL, O'Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O'Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Dávila-Román VG, McNulty SE, Borlaug BA, Mann DL, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM, Research Network NHFC. Low-dose Dopamine or low-dose Nesiritide in Acute Heart Failure with Renal Dysfunction: the ROSE Acute Heart Failure Randomized Trial. JAMA 310(23):2533-43, 2013. e-Pub 2013. PMID: 24247300.
190. Nambi V, Liu X, Chambless LE, de Lemos JA, Virani SS, Agarwal S, Boerwinkle E, Hoogeveen RC, Aguilar D, Astor BC, Srinivas PR, Deswal A, Mosley TH, Coresh J, Folsom AR, Heiss G, Ballantyne CM. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. Clin Chem 59(12):1802-10, 2013. e-Pub 2013. PMID: 24036936.
191. Huang HD, Alam M, Hamzeh I, Virani S, Deswal A, Aguilar D, Rogers P, Kougias P, Birnbaum Y, Paniagua D, Kar B, Ballantyne C, Bozkurt B, Jneid H. Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. Int J Cardiol 168(4):3741-6, 2013. e-Pub 2013. PMID: 23845772.
192. Bandeali SJ, Kayani WT, Lee VV, Elayda M, Alam M, Huang HD, Wilson JM, Jneid H, Birnbaum Y, Deswal A, Farmer J, Ballantyne CM, Virani SS. Association between preoperative diuretic use and in-hospital outcomes after cardiac surgery. Cardiovasc Ther 31(5):291-7, 2013. e-Pub 2013. PMID: 23517524.
193. Ather S, Bavishi C, McCauley MD, Dhaliwal A, Deswal A, Johnson S, Chan W, Aguilar D, Pritchett AM, Ramasubbu K, Wehrens XH, Bozkurt B. Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol 167(5):1912-7, 2013. e-Pub 2013. PMID: 22633437.
194. Ather S, Hira RS, Shenoy M, Fatemi O, Deswal A, Aguilar D, Ramasubbu K, Bolos M, Chan W, Bozkurt B. Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure. Int J Cardiol 166(2):394-8, 2013. e-Pub 2013. PMID: 22119115.
195. Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O'Connor CM, Felker GM, Goldsmith SR, Bart BA, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E, Trial R. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 309(12):1268-77, 2013. e-Pub 2013. PMID: 23478662.
196. Khalid U, Deswal A. ACP Journal Club. Review: in systolic heart failure, low-sodium diets increase mortality compared with normal-sodium diets. Ann Intern Med 158(4):JC7, 2013. e-Pub 2013. PMID: 23420258.
197. Bart BA, Goldsmith SR, Lee KL, Givertz MM, O'Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO, Stevenson LW, Semigran MJ, Felker GM, Chen HH, Hernandez AF, Anstrom KJ, McNulty SE, Velazquez EJ, Ibarra JC, Mascette AM, Braunwald E, Research Network HFC. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 367(24):2296-304, 2012. e-Pub 2012. PMID: 23131078.
198. Bishu K, Deswal A, Chen HH, LeWinter MM, Lewis GD, Semigran MJ, Borlaug BA, McNulty S, Hernandez AF, Braunwald E, Redfield MM. Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. Am Heart J 164(5):763-770.e3, 2012. e-Pub 2012. PMID: 23137508.
199. Ramasubbu K, Deswal A, Chan W, Aguilar D, Bozkurt B. Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial. J Card Fail 18(10):792-8, 2012. e-Pub 2012. PMID: 23040115.
200. Redfield MM, Borlaug BA, Mohammed SF, Lewis GD, Semigran MJ, Lewinter MM, Deswal A, Hernandez AF, Lee KL, Braunwald E, Research Network HFC. PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design. Circ Heart Fail 5(5):653-9, 2012. e-Pub 2012. PMID: 22991405.
201. Bozkurt B, Bolos M, Deswal A, Ather S, Chan W, Mann DL, Carabello B. New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients--a matter of time for contractility. J Card Fail 18(3):183-93, 2012. e-Pub 2012. PMID: 22385938.
202. Bart BA, Goldsmith SR, Lee KL, Redfield MM, Felker GM, O'Connor CM, Chen HH, Rouleau JL, Givertz MM, Semigran MJ, Mann D, Deswal A, Bull DA, Lewinter MM, Braunwald E. Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. J Card Fail 18(3):176-82, 2012. e-Pub 2012. PMID: 22385937.
203. Ather S, Chan W, Aguilar D, Bozkurt B, Ramasubbu K, Zachariah AA, Wehrens XH, Deswal A. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 59(11):998-1005, 2012. e-Pub 2012. PMID: 22402071.
204. Pritchett AM, Deswal A, Aguilar D, Foreyt JP, Chan W, Mann DL, Ballantyne C, Bozkurt B. Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study. J Obes Weight Loss Ther 2(2):1-8, 2012. e-Pub 2012. PMID: 23125955.
205. Desai RJ, Ashton CM, Deswal A, Morgan RO, Mehta HB, Chen H, Aparasu RR, Johnson ML. Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure. Pharmacoepidemiol Drug Saf 21(3):233-40, 2012. e-Pub 2012. PMID: 21786364.
206. Rosamond WD, Chang PP, Baggett C, Johnson A, Bertoni AG, Shahar E, Deswal A, Heiss G, Chambless LE. Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria. Circ Heart Fail 5(2):152-9, 2012. e-Pub 2012. PMID: 22271752.
207. Deswal A. Obesity, leptin, and incident heart failure. J Am Coll Cardiol 58(18):1878-80, 2011. e-Pub 2011. PMID: 22018298.
208. Ather S, Peterson LE, Divakaran VG, Deswal A, Ramasubbu K, Giorgberidze I, Blaustein A, Wehrens XH, Mann DL, Bozkurt B. Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data. Int J Cardiol 150(3):264-9, 2011. e-Pub 2011. PMID: 20471706.
209. Deswal A, Richardson P, Bozkurt B, Mann DL. Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). J Card Fail 17(8):634-42, 2011. e-Pub 2011. PMID: 21807324.
210. Subramanian D, Subramanian V, Deswal A, Mann DL. New predictive models of heart failure mortality using time-series measurements and ensemble models. Circ Heart Fail 4(4):456-62, 2011. e-Pub 2011. PMID: 21562057.
211. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O'Connor CM, Research Network NHFC. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364(9):797-805, 2011. e-Pub 2011. PMID: 21366472.
212. Ather S, Chan W, Chillar A, Aguilar D, Pritchett AM, Ramasubbu K, Wehrens XH, Deswal A, Bozkurt B. Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. Am Heart J 161(3):567-73, 2011. e-Pub 2011. PMID: 21392613.
213. Aguilar D, Chan W, Bozkurt B, Ramasubbu K, Deswal A. Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail 4(1):53-8, 2011. e-Pub 2011. PMID: 20952583.
214. Loehr LR, Rosamond WD, Poole C, McNeill AM, Chang PP, Deswal A, Folsom AR, Heiss G. The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study. Am J Epidemiol 172(7):781-9, 2010. e-Pub 2010. PMID: 20716703.
215. Ramasubbu K, Deswal A, Herdejurgen C, Aguilar D, Frost AE. A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance. Int J Gen Med 3(4):279-86, 2010. e-Pub 2010. PMID: 21042428.
216. Anand IS, Deswal A, Kereiakes DJ, Purkayastha D, Zappe DH. Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure. Vasc Health Risk Manag 6(1):449-55, 2010. e-Pub 2010. PMID: 20730060.
217. Bozkurt B, Mann DL, Deswal A. Biomarkers of inflammation in heart failure. Heart Fail Rev 15(4):331-41, 2010. e-Pub 2010. PMID: 19363700.
218. Cully JA, Phillips LL, Kunik ME, Stanley MA, Deswal A. Predicting quality of life in veterans with heart failure: the role of disease severity, depression, and comorbid anxiety. Behav Med 36(2):70-6, 2010. e-Pub 2010. PMID: 20497945.
219. Gordon HS, Nowlin PR, Maynard D, Berbaum ML, Deswal A. Mortality after hospitalization for heart failure in blacks compared to whites. Am J Cardiol 105(5):694-700, 2010. e-Pub 2010. PMID: 20185019.
220. Aguilar D, Deswal A, Ramasubbu K, Mann DL, Bozkurt B. Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol 105(3):373-7, 2010. e-Pub 2010. PMID: 20102951.
221. Ramasubbu, K, Deswal, A, Herdejurgen, C, Aguilar, D, Frost, A. A prospective Echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States. International Journal of General Medicine 3:279-286, 2010. e-Pub 2010.
222. Cully JA, Stanley MA, Deswal A, Hanania NA, Phillips LL, Kunik ME. Cognitive-behavioral therapy for chronic cardiopulmonary conditions: preliminary outcomes from an open trial. Prim Care Companion J Clin Psychiatry 12(4):e1-e6, 2010. e-Pub 2010. PMID: 21085552.
223. Cully JA, Johnson M, Moffett ML, Khan M, Deswal A. Depression and anxiety in ambulatory patients with heart failure. Psychosomatics 50(6):592-8, 2009. e-Pub 2009. PMID: 19996230.
224. Dhaliwal AS, Habib G, Deswal A, Verduzco M, Souchek J, Ramasubbu K, Aguilar D, Ma TS, Jneid HM, Bolos M, Bozkurt B. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Am J Cardiol 104(2):270-5, 2009. e-Pub 2009. PMID: 19576359.
225. Aguilar D, Bozkurt B, Ramasubbu K, Deswal A. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol 54(5):422-8, 2009. e-Pub 2009. PMID: 19628117.
226. Dhaliwal AS, Deswal A, Pritchett A, Aguilar D, Kar B, Souchek J, Bozkurt B. Reduction in BNP levels with treatment of decompensated heart failure and future clinical events. J Card Fail 15(4):293-9, 2009. e-Pub 2009. PMID: 19398076.
227. Cully JA, Jimenez DE, Ledoux TA, Deswal A. Recognition and treatment of depression and anxiety symptoms in heart failure. Prim Care Companion J Clin Psychiatry 11(3):103-9, 2009. e-Pub 2009. PMID: 19617942.
228. Dhaliwal AS, Chu D, Deswal A, Bozkurt B, Coselli JS, LeMaire SA, Huh J, Bakaeen FG. The July effect and cardiac surgery: the effect of the beginning of the academic cycle on outcomes. Am J Surg 196(5):720-5, 2008. e-Pub 2008. PMID: 18789415.
229. Hassan SA, Deswal A, Bozkurt B, Aguilar D, Mann DL, Pritchett AM. The metabolic syndrome and mortality in an ethnically diverse heart failure population. J Card Fail 14(7):590-5, 2008. e-Pub 2008. PMID: 18722325.
230. Ahmed A, Aboshady I, Munir SM, Gondi S, Brewer A, Gertz SD, Lai D, Shaik NA, Shankar KJ, Deswal A, Casscells SW. Decreasing body temperature predicts early rehospitalization in congestive heart failure. J Card Fail 14(6):489-96, 2008. e-Pub 2008. PMID: 18672197.
231. Das A, Abraham S, Deswal A. Advances in the treatment of heart failure with a preserved ejection fraction. Curr Opin Cardiol 23(3):233-40, 2008. e-Pub 2008. PMID: 18382212.
232. Deswal, A, Zhang, L. Treatment of heart failure with preserved systolic function in the elderly. Aging Health 4(2):157-170, 2008. e-Pub 2008.
233. Kazi D, Deswal A. Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure. Cardiol Clin 26(1):1-14, v, 2008. e-Pub 2008. PMID: 18312901.
234. Ramasubbu K, Estep J, White DL, Deswal A, Mann DL. Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J Am Coll Cardiol 51(4):415-26, 2008. e-Pub 2008. PMID: 18222351.
235. Aguilar D, Bozkurt B, Pritchett A, Petersen NJ, Deswal A. The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure. J Am Coll Cardiol 50(1):32-6, 2007. e-Pub 2007. PMID: 17601542.
236. Patel P, White DL, Deswal A. Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up. Am Heart J 153(4):515-22, 2007. e-Pub 2007. PMID: 17383287.
237. Abraham NS, El-Serag HB, Hartman C, Richardson P, Deswal A. Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident. Aliment Pharmacol Ther 25(8):913-24, 2007. e-Pub 2007. PMID: 17402995.
238. Deswal, A. Outcomes in women vs men with heart failure and preserved ejection fraction. Cardiology Review 24(3):24-27, 2007. e-Pub 2007.
239. Deswal A, Petersen NJ, Urbauer DL, Wright SM, Beyth R. Racial variations in quality of care and outcomes in an ambulatory heart failure cohort. Am Heart J 152(2):348-54, 2006. e-Pub 2006. PMID: 16875921.
240. Deswal A, Bozkurt B. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. Am J Cardiol 97(8):1228-31, 2006. e-Pub 2006. PMID: 16616031.
241. Bozkurt B, Deswal A. Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J 150(6):1233-9, 2005. e-Pub 2005. PMID: 16338264.
242. Deswal A, Mann DL. Can valsartan reduce the occurrence of atrial fibrillation in heart failure patients?. Nat Clin Pract Cardiovasc Med 2(10):502-3, 2005. e-Pub 2005. PMID: 16186843.
243. Deswal A. Diastolic dysfunction and diastolic heart failure: mechanisms and epidemiology. Curr Cardiol Rep 7(3):178-83, 2005. e-Pub 2005. PMID: 15865857.
244. Soltero ER, Petersen NJ, Earle NR, Glaeser DH, Urbauer DL, Deswal A. Long-term results of coronary artery bypass grafting in patients with ischemic cardiomyopathy: the impact of renal insufficiency and non-cardiac vascular disease. J Card Fail 11(3):206-12, 2005. e-Pub 2005. PMID: 15812749.
245. Singh H, Gordon HS, Deswal A. Variation by race in factors contributing to heart failure hospitalizations. J Card Fail 11(1):23-9, 2005. e-Pub 2005. PMID: 15704060.
246. Kazi D, Deswal A. Role and Optimal Dosing of ACE Inhibitors in Heart Failure. Heart Failure Clinics 1:25-38, 2005. e-Pub 2005. PMID: 17386831.
247. Agoston I, Cameron CS, Yao D, Dela Rosa A, Mann DL, Deswal A. Comparison of outcomes of white versus black patients hospitalized with heart failure and preserved ejection fraction. Am J Cardiol 94(8):1003-7, 2004. e-Pub 2004. PMID: 15476612.
248. Palaskas NL, Siddiqui BA, Deswal A. Steroids in Immune Checkpoint Inhibitor Myocarditis. JACC CardioOncol 6(5):800-803, 2004. e-Pub 2024. PMID: 39479336.
249. Deswal A, Petersen NJ, Souchek J, Ashton CM, Wray NP. Impact of race on health care utilization and outcomes in veterans with congestive heart failure. J Am Coll Cardiol 43(5):778-84, 2004. e-Pub 2004. PMID: 14998616.
250. Taylor AL, Ziesche S, Yancy C, et al.. Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure. N Engl J Med 351:2049-2057, 2004. e-Pub 2004. PMID: 15533851.
251. Mann DL, Deswal A. Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose. N Engl J Med 349(20):1963-5, 2003. e-Pub 2003. PMID: 14610159.
252. Moyé LA, Deswal A. Perils of the random experiment. Am J Ther 10(2):112-21, 2003. e-Pub 2003. PMID: 12629589.
253. Malave HA, Taylor AA, Nattama J, Deswal A, Mann DL. Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest 123(3):716-24, 2003. e-Pub 2003. PMID: 12628868.
254. Wilson EM, Gunasinghe HR, Bozkurt B, Lee-Jackson D, Coker ML, Sprunger P, Deswal A, Mann DL, Spinale FG. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. J Card Fail 8(6):390-8, 2002. e-Pub 2002. PMID: 12528092.
255. Moyé LA, Deswal A. The fragility of cardiovascular clinical trial results. J Card Fail 8(4):247-53, 2002. e-Pub 2002. PMID: 12397573.
256. Misra A, Diwan A, Mann DL, Deswal A. Asymptomatic left ventricular dysfunction: an overlooked part of the continuum of heart failure. Heart Fail Monit 3(2):42-8, 2002. e-Pub 2002. PMID: 12634879.
257. Misra, A, Diwan, A, Mann, D, Deswal, A. Asymptomatic left ventricular dysfunction. Heart failure monitor 3(2):42-48, 2002. e-Pub 2002. PMID: 2003068159.
258. Mann DL, Deswal A, Bozkurt B, Torre-Amione G. New therapeutics for chronic heart failure. Annu Rev Med 53:59-74, 2002. e-Pub 2002. PMID: 11818463.
259. Moyé LA, Deswal A. Trials within trials: confirmatory subgroup analyses in controlled clinical experiments. Control Clinical Trials 22(6):605-19, 2001. e-Pub 2001. PMID: 11738119.
260. Deswal A, Petersen NJ, Feldman AM, White BG, Mann DL. Effects of Vesnarinone on Peripheral Circulating Levels of Cytokines and Cytokine Receptors in Patients with Heart Failure: a report from the Vesnarinone Trial. Chest 120(2):453-9, 2001. e-Pub 2001. PMID: 11502643.
261. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103(16):2055-9, 2001. e-Pub 2001. PMID: 11319194.
262. Kalra D, Bozkurt B, Deswal A, Torre-Amione G, Mann DL. Experimental options in the treatment of heart failure: the role of cytokine antagonism. Heart Fail Monit 1(4):114-21, 2001. e-Pub 2001. PMID: 12634895.
263. Kalra, D, Bozkurt, B, Deswal, A, Torre-Amione, G, Mann, D. Experimental options in the treatment of heart failure. Heart failure monitor 1(4):114-121, 2001. e-Pub 2001. PMID: 2003051437.
264. Deswal A, Bozkurt B, Seta Y, Parilti-Eiswirth S, Hayes FA, Blosch C, Mann DL. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation 99(25):3224-6, 1999. e-Pub 1999. PMID: 10385494.
265. Gorcsan J, Deswal A, Mankad S, Mandarino WA, Mahler CM, Yamazaki N, Katz WE. Quantification of the myocardial response to low-dose dobutamine using tissue Doppler echocardiographic measures of velocity and velocity gradient. Am J Cardiol 81(5):615-23, 1998. e-Pub 1998. PMID: 9514460.
266. Deswal, A, Mankad, S, Mahler, CM, Mandarine, WA, Katz, WE, John, G. Quantification of incremental alterations in regional myocardial function induced by low dose dobutamine using tissue Doppler imaging. Journal of the American Society of Echocardiography 10(4):409, 1997. e-Pub 1997.
267. Shan, K, Kurrelmeyer, K, Seta, Y, Wang, F, Dibbs, Z, Deswal, A, Lee-Jackson, D, Mann, D. The role of cytokines in disease progression in heart failure. Curr Opin Cardiol 12(3):218-223, 1997. e-Pub 1997. PMID: 9243078.
268. Bhadoria DP, Srivastava AK, Sharma M, Deswal A, Bhadoria P, Malhotra KK. Safe Use of Clonidine, Nifedipine and Vitamin K in Hepatic Porphyria. J Assoc Physicians India 36(11):675-6, 1988. e-Pub 1988. PMID: 3248999.
269. Bhadoria DP, Srivastava AK, Sharma M, Deswal A, Malhotra KK. Ranitidine and Acute Intermittent Porphyria. J Assoc Physicians India 36(4):295-6, 1988. e-Pub 1988. PMID: 3182690.

Invited Articles

1. Ali H, Sahay S, Deswal A, Faiz SA. Evaluation of Pulmonary Hypertension in Patients With Cancer. American College of Cardiology online (ACC.org), 2025.
2. Manohar H, Potter AS, Koutroumpakis E, Deswal A, Palaskas NL. Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer? Coronary Heart Disease. Curr Atheroscler Rep 24(8):599-606, 2022. e-Pub 2022. PMID: 35624391.
3. Shobayo F, Bajwa M, Koutroumpakis E, Hassan SA, Palaskas NL, Iliescu C, Abe JI, Mouhayar E, Karimzad K, Thompson KA, Deswal A, Yusuf SW. Acute coronary syndrome in patients with cancer. Expert Rev Cardiovasc Ther 20(4):275-290, 2022. e-Pub 2022. PMID: 35412407.
4. Liu J, Deswal A, Khalid U. COVID-19 myocarditis and long-term heart failure sequelae. Curr Opin Cardiol 36(2):234-240, 2021. e-Pub 2021. PMID: 33394709.
5. Walther CP, Triozzi JL, Deswal A. Iron deficiency and iron therapy in heart failure and chronic kidney disease. Curr Opin Nephrol Hypertens 29(5):508-514, 2020. e-Pub 2020. PMID: 32701598.
6. Shah T, Kampangkaew J, Przybylowicz R, Deswal A. Ularitide in Acute Heart Failure. Curr Emerg Hosp Med Rep 6(17), 2018. e-Pub 2018.
7. Mandviwala T, Khalid U, Deswal A. Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?. Curr Atheroscler Rep 18(5):21, 2016. e-Pub 2016. PMID: 26973130.
8. Shah T, Deswal A. How to Use Entresto in patients with Heart Failure?. Texas ACC Chapter Blog, 2015. e-Pub 2015.
9. Khalid U, Deswal A. Obesity and Heart Failure. Texas ACC Chapter Blog, 2015. e-Pub 2015.
10. Deswal A, Bozkurt B. Treatment of patients with heart failure and preserved ejection fraction. Curr Treat Options Cardiovasc Med 10(6):516-28, 2008. e-Pub 2008. PMID: 19026182.
11. Ramasubbu K, Mann DL, Deswal A. Anti-angiotensin therapy: new perspectives. Cardiol Clin 25(4):573-80; vi-vii, 2007. e-Pub 2007. PMID: 18063161.
12. Deswal A. Outcomes in Women vs. Men with Heart Failure and Preserved Ejection Fraction. Cardiology Review 24:24-27, 2007. e-Pub 2007.
13. Kazi D, Deswal A. Role and optimal dosing of angiotensin-converting enzyme inhibitor therapy. Heart Fail Clin 1(1):25-37, 2005. e-Pub 2005. PMID: 17386831.
14. Deswal A, Mann DL. Can Valsartan reduce the occurrence of atrial fibrillation in heart failure patients?. Nature Clin Pract Cardiovasc Med 2:502-503, 2005. e-Pub 2005.
15. Deswal A, Yao D. Aldosterone Receptor Blockers in the Treatment of Heart Failure. Curr Treat Options Cardiovasc Med 6(4):327-334, 2004. e-Pub 2004. PMID: 15212727.
16. Deswal A, Mann DL. Commentary on Valsartan in Acute Myocardial Infarction Trial (VALIANT). Practical Medicine (Polish) 12(154):159-160, 2003. e-Pub 2003.
17. Deswal A, Misra A, Bozkurt B. The role of anti-cytokine therapy in the failing heart. Heart Fail Rev 6(2):143-51, 2001. e-Pub 2001. PMID: 11309533.
18. Bozkurt B, Deswal A, Mann DL. Left Ventricular Remodeling in the Failing Human Heart: Basic Mechanisms and Treatment. Cardiology Special Edition 6:11-13, 2000. e-Pub 2000.
19. Torre-Amione G, Bozkurt B, Deswal A, Mann DL. An overview of tumor necrosis factor alpha and the failing human heart. Curr Opin Cardiol 14(3):206-10, 1999. e-Pub 1999. PMID: 10358791.
20. Torre-Amione G, Bozkurt B, Deswal A, Mann DL. Tumor Necrosis Factor-a and the Failing Human Heart: An Overview. Curr Opin Cardiol 14:206-210, 1999. e-Pub 1999.

Manuals, Teaching Aids, Other Teaching Publications

1. Deswal A, Tomas. Five Podcasts: BTKi and Immunotherapy Cardiotoxicities – Applying Guidelines and Expert Perspectives to Clinical Cases,. Projects In Knowledge Powered by Kaplan, 2023.
2. Deswal A. Clinical Practice Guidelines/Recommendations: VHA Prosthetic Clinical Management Program (PCMP) Clinical Practice Recommendations on the Use of Left Ventricular Assist Devices (LVADs) for Destination Therapy for Patients with End Stage Heart Failure, 2004.

Editorials

1. Ali HJ, Deswal A, ACP. In adults with HF with preserved ejection fraction and obesity, tirzepatide reduced a composite of CV death or worsening HF at 2 y. Ann Intern Med 178(4):JC43, 2025. PMID: 40163881.
2. Deswal, A, Kumar, S. Finding a Signal in the Noise: Exploring Comorbidity Clusters to Personalize Acute Heart Failure Care. JACC: Heart Failure 12(10):1775-1777, 2024. PMID: 39152984.
3. Yang EH, Deswal A. Moving theory and reality closer together in cardio-oncology training. European Journal of Heart Failure 26(4):772-775, 2024. PMID: 38506341.
4. Koutroumpakis, E, Deswal A. In adults with overweight or obesity and CVD, but without diabetes, semaglutide reduced MACE at a mean 40 mo. Ann Intern Med 177(3):JC31, 2024. PMID: 38437690.
5. Deswal A, Ali Hyeon-Ju. In patients with HFpEF and obesity, semaglutide increased weight loss and reduced symptoms and physical limitations at 52 wk. Ann Intern Med 176(12):JC136, 2023. PMID: 38048584.
6. Bozkurt, B, Desai, AS, Ahmad, T, Deswal, A, Heidenreich, PA, Ibrahim, NE, McMurray, JJ, Pinney, SP, Vaduganathan, M, Walsh, MN. As We Embark on a Second Year. JACC: Heart Failure 11(10):1466-1469, 2023. PMID: 37793737.
7. Deswal A, Piccini J. Catheter Ablation of Atrial Fibrillation in Persons With HFpEF: We Can All Breathe Easier Now!. ACC Heart Fail , 2023. PMID: 37115130.
8. Mentz RJ, Kittipibul V, Deswal A. Noncardiac Comorbidities in Chronic Heart Failure: More Is Worse, What Else Do We Know?. JACC Heart Fail 11(10):1377-1379, 2023. PMID: 37452804.
9. Koutroumpakis E, Deswal A. In thrombotic antiphospholipid syndrome, DOACs vs. VKAs increase arterial thrombotic events but not major bleeding. Ann Intern Med 176(4):JC43, 2023. PMID: 37011391.
10. Deswal A, Piccini JP. Catheter Ablation of Atrial Fibrillation in Persons With HFpEF: We Can All Breathe Easier Now!. JACC Heart Fail 11(6):659-661, 2023. PMID: 37115130.
11. Karimzad K, Deswal A. In older patients with permanent AF and HF, digoxin and bisoprolol did not differ for QoL at 6 mo. Ann Intern Med 174(6):JC69, 2021. PMID: 34058112.
12. Palaskas NL, Deswal A. In heart failure, adding empagliflozin to medical therapy reduced a composite of CV death or HF hospitalization. Ann Intern Med 173(10):JC51, 2020. PMID: 33197352.
13. Navaneethan SD, Yan J, Deswal A. Classification of Pulmonary Hypertension in CKD. Am J Kidney Dis 75(5):690-692, 2020. PMID: 32008859.
14. Khalid U, Jneid H, Deswal A. Higher risk, high yield: renin-angiotensin system blockade after percutaneous coronary intervention in patients with acute coronary syndrome. Rev Esp Cardiol (Engl Ed) 73(2):104-106, 2020. PMID: 31575483.
15. Abe JI, Yusuf SW, Deswal A, Herrmann J. Cardio-Oncology: Learning From the Old, Applying to the New. Front Cardiovasc Med 7:601893, 2020. PMID: 33324688.
16. Deswal A. Heart Failure With Reduced Ejection Fraction and Renal Dysfunction: Beta-Blockers Do Not Disappoint. J Am Coll Cardiol 74(23):2905-2907, 2019. PMID: 31806134.
17. Khalid U, Deswal A. Lack of definitive evidence for the use of renin-angiotensin system antagonists for heart failure with preserved ejection fraction. Evid Based Med 18(6):226-7, 2013. PMID: 23585078.
18. Deswal A, Basra SS. Incident cancer in patients with heart failure: causation or mere association?. J Am Coll Cardiol 62(10):887-8, 2013. PMID: 23810872.
19. Khalid, U, Deswal, A. In systolic heart failure, low-sodium diets increase mortality compared with normal-sodium diets. Annals of Internal Medicine 158(4):JC7, 2013. PMID: 23420258.
20. Deswal A. B-type natriuretic peptide consistently predicts death and cardiovascular events in heart failure. Ann Intern Med 143(2):53, 2005. PMID: 16134927.

Abstracts

1. . Major adverse cardiovascular events in patients with melanoma receiving immune checkpoint inhibitors. e-Pub 2023.
2. Ghosh A, Ali A, Song J, Wanna C, Niku A, Palaskas NL, Hamzeh I, Iliescu C, Karimzadehnajar K, Deswal A. Atrial Fibrillation is Associated with Almost a TH, 2023. e-Pub 2023.
3. Yarrabothula AR, Alsheikh-Kassim M, Amatullah A, Fossas J, Salman J, Seal Z, Lin H, Irizarry-Caro JA, Wanna C, Miller C, Fatakdawala M, Palaskas NL, Deswal A, Koutroumpakis E. Tolerability of Sacubitril-Valsartan in Patients with Cancer and Heart Failure with Reduced Ejection Fraction. J Am Coll Cardiol. 2023 Mar, 81 (8_Supplement) 2325. https://doi.org/10.1016/S0735-1097(23)02769-9, 2023. e-Pub 2023.
4. Pei D, Ulhaq O, Go R, Ali A, Khalaf S, Hamzeh I, Koutroumpakis E, Iliescu C, Deswal A, Palaskas NL. Risk Factors for Cardiovascular Events in Patients with Cancer Treated with Ponatinib. J Am Coll Cardiol. 2023 Mar, 81 (8_Supplement) 2204. https://doi.org/10.1016/S0735-1097(23)02648-7, 2023. e-Pub 2023.
5. Ali A, Zehner C, Song J, Yarrabothula AR, Irizarry-Caro JA, Miller C, Fatakdawala M, Lohray R, Tomakin G, Palaskas NL, Deswal A, Iliescu C, Koutroumpakis AE. High Central Venous Pressure and Pulmonary Vascular Resistance Independently Predict Mortality in Patients with Biopsy-Proven Cardiac AL Amyloidosis. J Am Coll Cardiol. 2023 Mar, 81 (8_Supplement) 2229. https://doi.org/10.1016/S0735-1097(23)02673-6, 2023. e-Pub 2023.
6. Ynalvez LA, Monlezun D, Hust M, Madjid M, Alexandrescu S, Koutroumpakis E, Palaskas NL, Honan K, Liu VY, Cilingiroglu M, Marmagkiolis K, Deswal A, Smalling RW, Iliescu AC. COVID-19 Complicated by Respiratory Failure Increases Inpatient STEMI Mortality: Machine Learning Augmented Modified Propensity Score Adjusted Longitudinal Cohort Study. J Am Coll Cardiol. 2023 Mar, 81 (8_Supplement) 2300. https://doi.org/10.1016/S0735-1097(23)02744-4, 2023. e-Pub 2023.
7. Ali A, Pina G, Zaman Shah KM, Koutroumpakis E, Hamzeh I, Yusuf SW, Iliescu C, Deswal A, Palaskas NL. Clinical HF, Cardiac Filling Pressures on Invasive Hemodynamics and NTPROBNP Levels in Patients with Immune Checkpoint Myocarditis. J Am Coll Cardiol. 2023 Mar, 81 (8_Supplement) 2284. https://doi.org/10.1016/S0735-1097(23)02728-6, 2023. e-Pub 2023.
8. Ali A, Palaskas N, Song J, Bourdillon M, Koutroumpakis E, Hamzeh I, Khalaf S, Durand J, Deswal A, Iliescu C. CRT-600.15 CardioMEMS-Guided Heart Failure Management in Cardio-Oncology Patients: A Tertiary Care Cancer Center Experience. J Am Coll Cardiol Intv. 2023 Feb, 16 (4_Supplement) S82. https://doi.org/10.1016/j.jcin.2023.01.260, 2023. e-Pub 2023.
9. Potter AS, Hulsukar MM, Wu L, Narasimhan B, Karimzad K, Koutroumpakis E, Palaskas N, Deswal A, Kantharia BK, Wehrens XH. Kinase Inhibitors and Atrial Fibrillation. J Am Coll Cardiol EP. null2023, 0 (0) . https://doi.org/10.1016/j.jacep.2022.11.034, 2023. e-Pub 2023.
10. Nowatzke J, Guedeney P, Palaskas N, Lehmann L, Ederhy S, Zhu H, Cautela J, Francis S, Courand P, Deswal A, Ewer SM, Aras M, Arangalage D, Ghafourian K, Fenioux C, Finke D, Peretto G, Zaha V, Ben Zadok OI, Tajiri K, Weppler A. Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry, 2022. e-Pub 2022. PMID: 36030143.
11. Kotla S, Imanishi M, Li S, Ko KA, Samanthapudi VK, Savage H, Schadler K, Shen YH, Deswal A, Lin S, Reyes-Gibby C, Yeung S, Pownall HJ, Fujiwara K, Burks JK, Le N, Wang G, Abe J. Abstract 232: Qualitative Single-cell Assessment By Imaging Mass Cytometry (imc) Analysis Reveals Senescence-associated Stemness (sas) Induced By Erk5 S496 Phosphorylation In Atherosclerotic Plaque. Poster Abstract Presentations Session Title: Poster Session 1, 2022. e-Pub 2022.
12. Palaskas N, Lu Y, Caldwell R, Oderinde P, Pina G, Ali A, Shah K, Iliescu C, Yusuf SW, Koutroumpakis E, Khalaf S, Hamzeh I, Siddiqui B, Subudhi S, Deswal A. Use of Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor Myocarditis; J Immunother Cancer 2022:10(Suppl 2):A1-A1595, 2022. e-Pub 2022.
13. Imanishi M, Cheng H, Kotla S, Lin S, Deswal A, Ko K, Samanthapudi V, Le N, Fujiwara K, Liao Z, Palaskas NL, Yusuf SW, Nurieva RI, Reyes-Gibby C, Yeung S, Amir ED, Burks JK, Kobayashi M, Yoshimoto M, Abe J. Abstract 503: Multiparameter Mass Cytometry Reveals The Unique Response Of NaïVe B Cell Cd27- Subset With The Increase Of T-bet And Cd38 Expression After Radiation Therapy In Thoracic Cancer Patients. Poster Abstract Presentation Session Title: Poster Session 3, 2022. e-Pub 2022.
14. Li S, Kotla S, Imanishi M, Ko KA, Samanthapudi V, Savage H, Schadler K, Deswal A, Lin S, Reyes-Gibby C, Yeung S, Pownall HJ, Fujiwara K, Le N, Wang G, Abe J. Abstract 244: Differentially Expressed Genes Mediated By Erk5 S496 Phosphorylation In Hypercholesterolemia-induced Macrophage Reprogramming. Poster Abstract Presentation Session: Poster Session 1, 2022. e-Pub 2022.
15. Kotla S, Imanishi M, Zhang A, Ko KA, Samanthapudi V, Savage H, Schadler K, Abe R, Deswal A, Lin S, Reyes-Gibby C, Yeung S, Pownall HJ, Fujiwara K, Hamilton D, Li S, Wang G, Le N, Abe J. Abstract 518: Erk5 S496 Phosphorylation, But Not Erk5 Kinase Or Transcriptional Activity, Is Responsible For Promoting Macrophage Inflammation And Mitochondrial Dysfunction Via Upregulating Novel Site Of Nrf2 K518 Sumoylation. Poster Abstract Presentation Session Title: Poster Session 3, 2022. e-Pub 2022.
16. Baldassarre LA, Ganatra S, Lopez-Mattei J, Yang EH, Zaha VG, Wong TC, Ayoub C, DeCara JM, Dent S, Deswal A, Ghosh AK, Henry M, Khemka A, Leja M, Rudski L, Villarraga HR, Liu JE, Barac A, Scherrer-Crosbie M. Advances in Multimodality Imaging in Cardio-Oncology. J Am Coll Cardiol 80(16):1560–1578, 2022. e-Pub 2022.
17. Koutroumpakis E, Niku A, Black CK, Sadaf H, Song J, Palaskas NL, Iliescu C, Durand J, Deswal A, Buja LM, Banchs J. Abstract 12022: Predictors of Mortality in Patients With Biopsy-Proven Cardiac AL Amyloidosis. Originally published30 Oct 2022Circulation. 2022;146:A12022, 2022. e-Pub 2022.
18. Fatakdawala M, Irizarry-Caro J, Amatullah A, Yarrabothula A, Miller C, Wanna C, Mouhayar E, Iliescu C, Palaskas NL, Deswal A, Koutroumpakis E. Abstract 13827: Performance Characteristics of Natriuretic Peptides in Predicting Invasively Measured Intracardiac Filling Pressures in Patients With Cancer. Originally published30 Oct 2022Circulation. 2022;146:A13827, 2022. e-Pub 2022.
19. Wanna C, Black C, Niku A, Song J, Fatakdawala M, Yarrabothula A, Irizarry-Caro J, Miller C, Yusuf SW, Palaskas NL, Iliescu C, Durand J, Mouhayar E, Banchs J, Karimzad K, Deswal A, Koutroumpakis E. Abstract 13845: Atrial Fibrillation in Patients With Biopsy-Proven Cardiac Al Amyloidosis; A Cancer Center Experience. Originally published30 Oct 2022Circulation. 2022;146:A13845 Abstract, 2022. e-Pub 2022.
20. Koutroumpakis E, TING XU, Lopez-Mattei J, Gilchrist S, Corrigan K, Pan T, Lu Y, Mohan R, Zhang X, Meng Q, Lin R, Xu T, Deswal A, Liao Z. Abstract 13415: Coronary Calcium Score on Standard of Care Oncologic CT Scans for the Prediction of Adverse Cardiovascular Events in Patients With Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiotherapy. Originally published30 Oct 2022Circulation. 2022;146:A13415, 2022. e-Pub 2022.
21. Avula V, Sharma G, Kosiborod MN, Vaduganathan M, Neilan TG, Lopez-Fernandez T, Dent SF, Baldassarre LA, Scherrer-Crosbie M, Scherrer-crosbie M, Barac A, Liu J, Deswal A, Yang EH, Ky B, Lenihan D, Lenihan D, Nohria A, Nohria A, Dani S, Ganatra S. Abstract 11850: Association Between SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Antineoplastic Therapy Associated Cardiomyopathy and Heart Failure. Originally published 30 Oct 2022 Circulation. 2022;146:A11850, 2022. e-Pub 2022.
22. Potter AS, Pierce E, Caldwell R, Pina G, Oderinde P, Koutroumpakis E, Iliescu C, Deswal A, Palaskas NL. Abstract 14762: Prospective Study Evaluating Management of Hypertension Induced by Anti-VEGF Therapy in Patient With Active Cancer: Preliminary Report From the VEGFHTN Trial; Originally published30 Oct 2022Circulation. 2022;146:A14762, 2022. e-Pub 2022.
23. Aziz M, Koutroumpakis E, Deswal Anita, Monlezun D, Thomason N, Abe J, Otchere P, Palaskas NL, Jabbour E, Kim P, Lopez-Mattei J, Cilingiroglu M, Marmagkiolis K, Feldman MD, Iliescu C. Abstract 14372: Case Series: Non-Lipid Plaque Formation as the Mechanism for Ponatinib-Induced Vascular Toxicity Using Operator-Assisted Virtual Histology Optical Coherence Tomography. Originally published30 Oct 2022Circulation. 2022;146:A14372, 2022. e-Pub 2022.
24. Ganatra S, Sourbha S Dani, Kumar A, Safi U Khan, Rishi Wadhera, Tomas G Neilan, Paaladinesh Thavendiranathan, Ana Barac, Joerg Hermann, Leja M, Anita Deswal, Michael Fradley, Jennifer E Liu, Diego Sadler, Aarti Asnani, Lauren A Baldassarre, Dipti Gupta, Eric Yang, Avirup Guha, Sherry-Ann Brown, Stevens PJ. Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United States. J Am Coll Cardiol CardioOnc 4(3):326-337, 2022. e-Pub 2022.
25. Honan KA, Hassan S, Deswal A, Song J, Halperin D, Dasari A, Akkanti B, Marmagkiolis K, Gregoric I, Patel M, Nathan S, Yao J, Iliescu CA. D-43 | Bioprosthetic Valve Monitoring in Patients with Carcinoid Heart Disease. DOI:https://doi.org/10.1016/j.jscai.2022.100248 1(3), 2022. e-Pub 2022.
26. Sadler DB, Moudgil R, Arco T, Patrick H Collier III, Sarkar A, Barac A, Ann BS, Herrmann J, Deswal A, Investigators G. Global Cardio Oncology Registry: Structure for a Multinational Collaboration. AHA Scientific Sessions 2021, 2021. e-Pub 2021.
27. Patel A, Muzamil, Khawaja, Chen CR, Zheng H, Morgan J, Kaczmarek J, Gao F, Karimzad K, Song J, Lopez-Mattei J, Iliescu C, Deswal A, Palaskas NL. Outcomes of Stroke and Bleeding by Class of Anticoagulant Use for Non-Valvular Atrial Fibrillation in Patients With Active Cancer. AHA Scientific Sessions 2021, 2021. e-Pub 2021.
28. Bruera S, Lei MX, Blau PB, Zhao MH, Deswal A, Yazdany MJ. Increased Risk of Major Adverse Cardiac Events in Patients with Systemic Lupus Erythematosus After Non-Cardiac Surgery. ACR Convergence 2021, 2021. e-Pub 2021.
29. Ganatra S, Dani S, Kumar A, Khan SU, Neilan T, Thavendiranathan P, Scarborough, Barac A, Hermann J, Leja M, Deswal A, Fradley M, Liu J, Ky B, Sadler DB, Asnani A, Baldassarre LA, Gupta D, Yang E, Brown S, Wadhera R, Kazi DS, Stevens JP, Hayek S, Baron SJ, Nasir K, Nohria A. Impact of Social Vulnerability on Cardio-Oncology Mortality in the United States. American Heart Association Scientific Sessions, 2021. e-Pub 2021.
30. Hirsch JR, Rifai MA, Navaneethan S, Deswal AM. Mortality Among Patients With Heart Failure After Initiation of Hemodialysis. AHA Scientific Sessions 2021, 2021. e-Pub 2021.
31. Steiner RE, Banchs J, Koutroumpakis E, Becnel M, Gutierrez C, Strati P, Pinnix C, Feng L, Claussen C, Palaskas N, Karimzad K, Ahmed S, Neelapu S, Shpall E, Wan M, Vega F, Westin J, Nastoupil L, Deswal A. Cardiovascular Events Amoung Adult Patients with Agressive B-Cell Lymphoma Treated with Standard of Care Axicabtagne Ciloleucel and Tisagenlecleucel. International Conference of Malignant Lymphoma, 2021. e-Pub 2021.
32. Orimoloye O, Power JR, Nowatzke J, Hughes AM, Lehmann L, Cautela J, Aras M, Weppler A, Narezkina A, Peretto G, Pela M, Crusz SM, Asnani A, Salem J, Deswal A, Palaskas N, Moslehi J. Echocardiographic Features of Immune Checkpoint Inhibitor Associated Myocarditis and Their Association With Adverse Outcomes. Circulation, 2021. e-Pub 2021.
33. Batra A, Patel B, Addison D, Baldassarre L, Desai N, Weintraub N, Deswal A, Hussain Z, Brown S, Ganatra S, Agarwala V, Parikh P, Fradley M, Ghosh A, Guha A. Cardiovascular Safety Profile of Taxanes and Vinca Alkaloids: 30-Years Fda Registry Experience. Circulation, 2021. e-Pub 2021.
34. Batra A, Patel B, Addison D, Baldassarre L, Desai N, Weintraub N, Deswal A, Hussain Z, Brown S, Ganatra S, Agarwala V, Parikh P, Fradley M, Ghosh A, Guha A. Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience. JAAC Journal 77(18), 2021. e-Pub 2021.
35. Kabani S, Daher M, Segura A, Bihong Z, Lelenwa L, Buja M, Iliescu C, Deswal A, Palaskas N. Immune Checkpoint Inhibitor Myocarditis: Hemodynamics on Presentation. Circulation, 2021. e-Pub 2021.
36. Aldrich J, Pundole X, Tummala S, Andersen C, Abdel-Wahab N, Palaskas N, Deswal A, Suarez-Almazor M. Immune checkpoint inhibitor-related myositis: a retrospective cohort study. Annals of the Rheumatic Diseases 79:395, 2020. e-Pub 2020.
37. Aldrich J, Pundole X, Tummala S, Andersen C, Shoukier M, Abdel-Wahab N, Palaskas N, Deswal A, Suarez-Almazor, ME. Incidence and outcomes of immune checkpoint inhibitor-related myositis. Journal of Clinical Oncology, 2020. e-Pub 2020.
38. Serauto A, Lee M, Lopez-Mattei JC, Gill C, Donisan T, Balanescu D, Marmagkiolis K, Palaskas N, Kim PY, Deswal A, Iliescu AC. Hematological Malignancies with Thrombocytopenia Undergoing Primary Percutaneous Pericardiocentesis: Periprocedural (30-day) Overall Survival Analysis. J Am Coll Cardiol 75 (11_Supplement_1) 1510, 2020. e-Pub 2020.
39. Aziz M, Balanescu D, Donisan T, Song J, Palaskas N, Lopez-Mattei JC, Kim PY, Cilingiroglu M, Herrmann J, Marmagkiolis K, Deswal A, and Iliescu C. Intracoronary imaging-guided Discontinuation of Dual Antiplatelet Therapy in Stented Patients Requiring Expedited Cancer Treatment. J Am Coll Cardiol 75 (11_Supplement_1) 1408, 2020. e-Pub 2020.
40. Palaskas N, Lopez-Mattei JC, Kim PY, Cilingiroglu M, Marmagkiolis K, Deswal A, Iliescu AC. Early Resumption of Cancer Treatment After Percutaneous Coronary Intervention: Impact on cardiovascular outcomes. J Am Coll Cardiol 75 (11_Supplement_1) 1407, 2020. e-Pub 2020.
41. Palaskas N, Lopez-Mattei J, Deswal A. Lack of Correlation Between Cardiac Magnetic Resonance Imaging and Endomyocardial biopsy in Immune Checkpoint Inhibitor-Associated Myocarditis. ACC: Advancing Care of the Cardio-oncology Patient, 2020. e-Pub 2020.
42. Koutroumpakis E, Thannoun T, Pang J, Patel R, Grable C, Damaraju S, Mawji SB, Folivi M, Chauhan S, Fatakdawala M, Powell C, Shabbir MA, Philbin E, Lyubarova R, Damaraju S, Palaskas NL, Deswal A, Taegtmeyer H, Garcia-Sayan E. Baseline Comorbidities and Cardiac Biomarkers are Associated With In-hospital Mortality of Covid-19 Patients. Circulation 142(Suppl_3):A16352, 2020. e-Pub 2020.
43. Aziz M, Balanescu D, Donisan T, Song J, Palaskas N, Lopez-Mattei JC, Kim PY, Cilingiroglu M, Herrmann J, Marmagkiolis K, Anita Deswal, Cezar Iliescu. Intracoronary imaging-guided discontinuation of dual antiplatelet therapy in stented patients requiring expedited cancer treatment. ACC 2020, 2020. e-Pub 2020.
44. Aldrich J, Pundole X, Tummala S, Andersen C, Shoukier M, Abdel-Wahab N, Palaskas N, Deswal A, Suarez-Almazor ME. Incidence and outcomes of immune checkpoint inhibitor-related myositis. Journal of Clinical Oncology 38(15_suppl):e15128, 2020. e-Pub 2020.
45. Kotla S, Ko KA, Imanishi M, Banchs J, Palaskas NL, Yusuf SW, Fujiwara K, Le NT, Deswal A, Chung C, Lin SH, Abe J. P90rsk-mediated Erk5 S496 Phosphorylation and Poly (adp-ribose) Polymerase (parp) Activation Promote Monocyte/macrophage Priming in Mouse and Cancer Patients After Radiation Therapy (rt). Arteriosclerosis, Thrombosis, and Vascular Biology 40:A330, 2020. e-Pub 2020.
46. Fatakdawala M, Pang J, Patel R, Thannoun T, Grable C, Damaraju S, Mawji SB, Folivi M, Chauhan S, Powell C, Shabbir MA, Lyubarova R, Damaraju S, Palaskas NL, Deswal A, Taegtmeyer H, Garcia-Sayan E, Koutroumpakis E. Electrocardiographic Findings and Their Associations With Adverse Outcomes in Hospitalized Patients With COVID-19. Circulation 142(Suppl_3):A16107, 2020. e-Pub 2020.
47. Aziz M, Balanescu D, Donisan T, Song J, Palaskas N, Lopez-Mattei J, Kim P, Cilingiroglu M, Herrmann J, Marmagkiolis K, Deswal A, Iliescu C. Intracoronary Imaging-Guided Dual Antiplatelet Therapy Discontinuation in Cancer Patients with Cardiovascular Comorbidities. e-Pub 2020.
48. Kampangkaew J, Moran T, Nambi V, Deswal A, Misra A. Baseline right ventricular function is associated with reduced need of diuretics in patients with heart failure with improved ejection fraction. J Am Coll Card 73 (9 Supplement 1):786, 2019. e-Pub 2019.
49. Nambi V, Sun W, Mcevoy J, De Lemos J, Hoogeveen R, Virani S, Aguilar D, Shah A, Ndumele C, Deswal A, Matsushita K, Selvin E, Folsom A, Ballantyne CM. NTproBNPand Incident Cardiovascular Events Across Systolic Blood Pressure Categories in the Atherosclerosis Risk in Communities (ARIC) Study. J Am Coll Cardiol 71 (11 Supplement):A1815, 2018. e-Pub 2018.
50. Cunningham LC, Fonarow G, Yancy C, Sheng S, Matsouaka RA, DeVore A, Jneid H, Deswal A. Regional Variations in Heart Failure Quality of Care and Outcomes. Circulation 138, Suppl_1, 2018. e-Pub 2018.
51. Saeed A, Nambi V, Sun W, Virani S, Deswal A, Hoogeveen R, Wagenknecht, Taffet G, Matsushita K, Selvin E, Coresh J, De Lemos J, Ballantyne CM. Impact of Biomarkers on Short-Term Risk Prediction of Global Cardiovascular Events in Older Adults: Atherosclerosis Risk in Communities Study. J Am Coll Cardiol 71 (11 Supplement):A2668, 2018. e-Pub 2018.
52. Walther CP, Deswal A, Winkelmayer W, Morgan JA, Niu J, Cheema FH, Navaneethan S. Readmissions After Acute Kidney Injury (AKI) With Left Ventricular Assist Device (LVAD) Implantation: National Estimates. Circulation 138:A16406, 2018. e-Pub 2018.
53. Stehlik J, Schmalfuss C, Bozkurt B, Nativi-Nicolau J, Wegerich S, Rose K, Ray R, Schofield R, Deswal A, Sekaric J, Anand S, Richards D, Hanson H, Pipke M, Pham M. Continuous wearable monitoring analytics predict heart failure decompensation: the LINK-HF multi-center study. J Am Coll Card 71 (11 Supplement):A646, 2018. e-Pub 2018.
54. Saeed A, Nambi V, Sun W, Virani S, Deswal A, Hoogeveen R, Taffet G, Matsushita K, Selvin E, Coresh J, De Lemos J, Ballantyne CM. Levels of High Sensitivity Troponin T and Short Term Risk for Cardiovascular Events in Older Americans: Insights From the Atherosclerosis Risk in Communities Study. Circulation 136:A15162, 2017. e-Pub 2017.
55. Basra SS, Wang T, Simon D, Chiswell K, Virani S, Alam M, Nambi V, Denktas A, Deswal A, Bozkurt B, Ballantyne CM, Peterson E, Jneid H. Aspirin dosing in patients with acute myocardial infarction treated with ticagrelor: insight from the national cardiovascular data registry (ncdr). J Am Coll Cardiol 67 (13 Supplement):537, 2016. e-Pub 2016.
56. Cunningham L, Tanavin T, Alam M, Virani S, Bozkurt B, Deswal A, Nambi V, Jneid H. A multicenter study of the etiology and outcome of cardiac tamponade in the contemporary era. J Am Coll Cardiol 67 (13 Supplement):1466, 2016. e-Pub 2016.
57. Owen B, Hoff J, Aguilar D, Denktas A, Virani S, Lakkis N, Bozkurt B, Deswal A, Shah T, Misra A, Jneid H, Ballantyne C, Nambi V. Publication Rates of Abstracts Presented at Major Cardiovascular Subspecialty Conferences. Circulation 134:A20656, 2016. e-Pub 2016.
58. Griffin JM, Wruck LM, Silverman RK, Loehr LR, Russell SD, Matsushita K, Agarwal SK, Deswal A, Rosamond WD, Chang PP. Predictive Value of Changes in Serum Sodium in Patients with Acute Decompensated Heart Failure: The Atherosclerosis Risk in Communities Study. J Am Coll Cardiol 67(13):1421, 2016. e-Pub 2016.
59. Bilen O, Marks S, Wruck L, Khalid U, Virani S, Nambi V, Jneid H, Cunningham L, Chang P, Bozkurt B, Deswal A. Heart Rate as a Prognostic Marker in Heart Failure with Preserved Ejection Fraction. Circulation 132:A16254, 2015. e-Pub 2015.
60. Khalid, U, Awar, O, Verstovsek, G, Cheong, BY, Yellapragada, S, Jneid, H, Deswal, A, Virani, SS. Case report: isolated cardiac amyloidosis: an enigma unravelled. Methodist DeBakey cardiovascular journal 11(1):53-58, 2015. e-Pub 2015. PMID: 25793032.
61. Macedo FY, Chan W, Deswal A, Ramasubbu K, Civitello A, Bozkurt B. In patients with severe advanced heart failure, non-response to decrease LV filling pressure is not associated with worse survival and outcomes: insights from the escape (evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness) trial. J Am Coll Cardiol 65 (10 Supplement):A1018, 2015. e-Pub 2015.
62. Pokharel Y, Sun W, Virani SS, Nambi V, Hoogeveen RC, Chang PP, Ndumele C, Solomon S, Bozkurt B, Selvin E, Ballantyne CM, Deswal A. Premorbid Body Mass Index, High sensitivity Troponin-T and mortality after incident heart failure hospitalization: The atherosclerosis risk in communities study (ARIC). J Am Coll Cardiol 65:A1003, 2015. e-Pub 2015.
63. Kumar A, Paniagua D, Kar B, Deswal A, Alam M, Omer S, Bakaeen F, Rosengart T, Blaustein A, Bozkurt B, Jneid. Safety and Effectiveness of Balloon Aortic Valvuloplasty for severe aortic stenosis in the contemporary era. J Am Coll Cardiol 63 (12_S), 2014. e-Pub 2014.
64. Deshpande A, Kar B, Paniagua D, Alam M, Deswal A, Jneid H. Tandem Heart-Percutaneous Left Ventricular Assist Device Treatment for severe refractory cardiogenic shock: The DeBakey VA Experience. J Am Coll Cardiol 63 (12_S), 2014. e-Pub 2014.
65. Ndumele CE, Matsushita K, Sang Y, Lazo M, Agarwal SK, Nambi V, Deswal A, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E. NT-proBNP Predicts Incident Heart Failure Among Individuals in All BMI Categories. Circulation 129:AP0, 2014. e-Pub 2014.
66. Virani SS, Maddox TM, Chan PS, Tang F, Akeroyd JM, Risch S, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA. Provider Type and Quality of Outpatient Cardiovascular Disease Care, Implications for the Affordable Care Act: Insights from the NCDR®PINNACLE Registry. Circulation 130:A15347, 2014. e-Pub 2014.
67. Deshpande A, Kar A, Paniagua D, Alam M, Deswal A, Jneid H. Tandem heart – percutaneuous left ventricular assist device treatment for severe refractory cardiogenic shock: the Debakey VA experience. J Am Coll Cardiol 63 (12 Supplement):A1854, 2014. e-Pub 2014.
68. Gonçalves A, Jhund PS, Claggett B, Rosamond W, Deswal A, Aguilar D, Shah AM, Cheng S, Solomon SD. The Association between Alcohol Consumption and Risk of Heart Failure may be modified by Sex: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 129:AP026, 2014. e-Pub 2014.
69. Kumar A, Virani S, Bassett S, Alam M, Hira R, Caruso D, Paniagua D, Denktas A, Hamzeh I, Levine G, Ballantyne CM, Deswal A, Bozkurt B, Jneid. Persistent Thrombicyopneia after myocardial infarction is associated with increase short- and long-term mortality. Circulation 130:A19771, 2014. e-Pub 2014.
70. Hira RS, Kennedy K, Nambi V, Jneid H, Alam M, Basra SS, Ho PM, Deswal A, Ballantyne CM, Petersen LA, Virani SS. Frequency and Predictors of Inappropriate Aspirin Prescribing for Primary Prevention of Cardiovascular Disease: Insights from the NCDR® PINNACLE Registry. AHA Quality of Care and Outcomes Research Conference, 2014. e-Pub 2014.
71. Sharma K, Agarwal SK, Matsushita K, Chang PP, Shah AM, Kitzman AM, Kitzman DW, Deswal A, Loehr LR, Coresh J, Rosamond WD, Solomon SD, Russell SD. Race and gender differences in survival among hospitalized heart failure with preserved ejection fraction: the ARIC study. Circulation 130:A9759, 2014. e-Pub 2014.
72. Khalid U, Ather S, Bavishi C, Chan W, Loehr LR, Wruck LM, Rosamond WB, Chang PP, Coresh J, Virani S, Nambi V, Bozkurt B, Ballantyne CM, Deswal A. Obesity Paradox in Heart Failure: Not all Cardiac Cachexia. Circulation 128:A15840, 2013. e-Pub 2013.
73. Khalid U, Wruck LM, Quibrera PM, Bozkurt B, Nambi V, Virani S, Basra S, Agarwal S, Chang PP, Loehr L, Rosamond W, Ballantyne CM, Deswal A. BNP as a Prognostic Marker in Obese Patients With Acute Heart Failure With Preserved vs. Reduced Ejection Fraction. Circulation 128:A16598, 2013. e-Pub 2013.
74. Bavishi C, Ather S, Bozkurt B, Deswal A. Prognostic significance of hypoalbuminemia among ambulatory heart failure patients with reduced and preserved ejection fraction. Circulation 128:A16960, 2013. e-Pub 2013.
75. Aziz M, Donisan T, Balanescu D, Song J, Ntim W, Palaskas N, Lopez-Mattei J, Kim P, Cilingiroglu M, Marmagkiolis K, Deswal A, Iliescu C. Cardiovascular Outcomes of Early Cancer Treatment Resumption After Percutaneous Coronary Intervention.
76. Aziz M, Balanescu D, Donisan T, Song J, Palaskas N, Lopez-Mattei JC, Kim PY, Cilingiroglu M, Herrmann J, Marmagkiolis K, Deswal A, Iliescu AC. INTRACORONARY IMAGING-GUIDED DISCONTINUATION OF DUAL ANTIPLATELET THERAPY IN STENTED PATIENTS REQUIRING EXPEDITED CANCER TREATMENT.
77. Donisan T, Balanescu D, Aziz M, Song J, Ntim W, Palaskas N, Lopez-Mattei JC, Kim PY, Cilingiroglu M, Marmagkiolis K, Deswal A, Iliescu AC. EARLY RESUMPTION OF CANCER TREATMENT AFTER PERCUTANEOUS CORONARY INTERVENTION: IMPACT ON CARDIOVASCULAR OUTCOMES.
78. Koutroumpakis E, Hamden R, Deswal A, Tung P, Nambi V, Krause T, Aguilar D, Aguilar AD. CONTEMPORARY TREATMENT PATTERNS FOR NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS IN PATIENTS WITH AND WITHOUT CARDIOVASCULAR DISEASE.
79. Hussain A, Sun W, Deswal A, Lemos JD, Mcevoy J, Hoogeveen R, Matsushita K, Aguilar D, Bozkurt B, Virani SS, Shah AM, Selvin E, Ndumele C, Ballantyne CM, Nambi AV. ASSOCIATION OF NT-PROBNP, PULSE PRESSURE WITH HEART FAILURE AND CARDIOVASCULAR EVENTS: ATHEROSCLEROSIS RISK IN COMMUNNITIES (ARIC) STUDY.
80. Serauto A, Lee M, Lopez-Mattei JC, Gill C, Donisan T, Balanescu D, Marmagkiolis K, Palaskas N, Kim PY, Deswal A, Iliescu AC. HEMATOLOGICAL MALIGNANCIES WITH THROMBOCYTOPENIA UNDERGOING PRIMARY PERCUTANEOUS PERICARDIOCENTESIS: PERIPROCEDURAL (30-DAY) OVERALL SURVIVAL ANALYSIS.
81. Batra A, Patel B, Addison D, Baldassarre L, Desai N, Weintraub N, Deswal A, Hussain Z, Brown S, Ganatra S, Agarwala V, Parikh P, Fradley M, Ghosh A, Guha AA. CARDIOVASCULAR SAFETY PROFILE OF TAXANES AND VINCA ALKALOIDS: 30-YEARS FDA REGISTRY EXPERIENCE.
82. Kabani S, Daher M, Segura A, Bihong Z, Lelenwa L, Buja M, Iliescu C, Deswal A, Palaskas AN. IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS HEMODYNAMICS ON PRESENTATION.
83. Orimoloye O, Power JR, Nowatzke J, Hughes AM, Lehmann L, Cautela J, Aras M, Weppler A, Narezkina A, Peretto G, Pela M, Crusz SM, Asnani A, Salem J, Deswal A, Palaskas N, Moslehi AJ. ECHOCARDIOGRAPHIC FEATURES OF IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDITIS AND THEIR ASSOCIATION WITH ADVERSE OUTCOMES.
84. Hughes A, Power J, Orimoloye OA, Nowatzke JF, Tamura Y, Aras M, Asnani A, Courand P, Florido R, Hayek S, Zaha VG, Deswal A, Moslehi J, L Palaskas AN. CLINICAL SIGNIFICANCE OF PERICARDIAL EFFUSION IN PATIENTS HOSPITALIZED WITH IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDITIS.
85. Honan K, Monlezun D, Koutroumpakis E, Palaskas NL, Cilingiroglu M, Lopez-Mattei JC, Marmagkiolis K, Akkanti B, Kar B, Gregoric ID, Deswal A, Iliescu C, Hassan AS. TRICUSPID AND PULMONARY VALVE REPLACEMENT IN CARCINOID HEART DISEASE: INSIGHTS AND TRENDS FROM A NATIONALLY REPRESENTATIVE DATABASE.
86. Palaskas NL, Siddiqui B, Shah K, Koutroumpakis E, Iliescu C, Subudhi S, Deswal A. UPFRONT IMMUNOMODULATORY TREATMENT OF IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS.
87. Pei D, Ulhaq O, Go R, Ali A, Khalaf S, Hamzeh I, Koutroumpakis E, Iliescu C, Deswal A, L Palaskas AN. RISK FACTORS FOR CARDIOVASCULAR EVENTS IN PATIENTS WITH CANCER TREATED WITH PONATINIB.
88. Ali A, Zehner C, Song J, Yarrabothula AR, Irizarry-Caro JA, Miller C, Fatakdawala M, Lohray R, Tomakin G, Palaskas NL, Deswal A, Iliescu C, Koutroumpakis AE. HIGH CENTRAL VENOUS PRESSURE AND PULMONARY VASCULAR RESISTANCE INDEPENDENTLY PREDICT MORTALITY IN PATIENTS WITH BIOPSY-PROVEN CARDIAC AL AMYLOIDOSIS.
89. Pei D, Ulhaq O, Go R, Ali A, Khalaf S, Hamzeh I, Koutroumpakis E, Iliescu C, Deswal A, L Palaskas AN. RISK FACTORS FOR CARDIOVASCULAR EVENTS IN PATIENTS WITH CANCER TREATED WITH PONATINIB.
90. Ali A, Pina G, Zaman Shah KM, Koutroumpakis E, Hamzeh I, Yusuf SW, Iliescu C, Deswal A, L Palaskas AN. CLINICAL HF, CARDIAC FILLING PRESSURES ON INVASIVE HEMODYNAMICS AND NTPROBNP LEVELS IN PATIENTS WITH IMMUNE CHECKPOINT MYOCARDITIS.
91. Ynalvez LA, Monlezun D, Hust M, Madjid M, Alexandrescu S, Koutroumpakis E, Palaskas NL, Honan K, Liu VY, Cilingiroglu M, Marmagkiolis K, Deswal A, Smalling RW, Iliescu AC. COVID-19 COMPLICATED BY RESPIRATORY FAILURE INCREASES INPATIENT STEMI MORTALITY: MACHINE LEARNING-AUGMENTED MODIFIED PROPENSITY SCORE ADJUSTED LONGITUDINAL COHORT STUDY.
92. Ghosh A, Ali A, Song J, Wanna C, Niku A, Palaskas NL, Hamzeh I, Iliescu C, Karimzadehnajar K, Deswal A. Atrial Fibrillation is Associated with almost a Three-Fold Increase in Mortality Risk in Patients with Biopsy-Proven Cardiac AL Amyloidosis.
93. Ali A, Koutroumpakis E, Song J, Palaskas NL, Deswal A. CARDIO-ONCOLOGY SESSION TITLE: CANCER THERAPY-RELATED CARDIAC DYSFUNCTION: FROM ANTHRACYCLINES TO NEW TARGETED THERAPIES.
94. Koduri A, Chauhan S, Chacon Portillo MA, Amatullah A, Miller C, strang A, tsai J, vachhani S, THAKAR D, Pollard J, Kry S, Shah S, Wagner D, Lopez D, Song J, Shah K, Iliescu C, Durand J, Deswal A, Karimzad K. ELECTROPHYSIOLOGY AND ARRHYTHMIAS SESSION TITLE: INNOVATIONS IN PACING, DEFIBRILLATION AND ARRHYTHMIA THERAPIES.
95. Yarrabothula AR, Alsheikh-Kassim M, Amatullah A, Fossas J, Salman J, Seal Z, Lin H, Irizarry-Caro JA, Wanna C, Miller C, Fatakdawala M, Palaskas NL, Deswal A, Koutroumpakis AE. TOLERABILITY OF SACUBITRIL-VALSARTAN IN PATIENTS WITH CANCER AND HEART FAILURE WITH REDUCED EJECTION FRACTION.
96. Bourdillon M, Ali A, Reardon MJ, Hamzeh I, Palaskas N, Deswal A, Khalaf AS. Cardiac Magnetic Resonance Imaging in Characterizing a Large Right Atrial Mass.
97. Randazzo M, Cotella JI, Maurer MS, Scherrer-Crosbie M, Soltani M, Goyal A, Zareba KM, Cheng RK, Yogeswaran V, Kitano T, Takeuchi M, Fernandes F, Hotta VT, Vieira ML, Elissamburu P, Ronderos RE, Prado A, Koutroumpakis E, Deswal A, Pursnani A, Sarswat N, Addetia K, Asch FM, Lang RM, Slivnick AJ. LIMITATIONS OF ECHOCARDIOGRAPHIC APICAL-SPARING STRAIN PATTERN IN CARDIAC AMYLOIDOSIS: A MULTICENTER STUDY.
98. Sadler DB, Rao VU, Moudgil R, Narezkina AD, Bauer BS, Garg V, Patel B, Akhter N, Das MK, Deswal A, Asnani A, Guerrero PA, Nikolova A, Copeland-Halperin RS, Cheng RK, Herrmann J, DeCara JM, Alomar M, Lenneman CG, Guha A, Franco FX, Brown QF, Karamlou T, Menon AV. THE GLOBAL CARDIO-ONCOLOGY REGISTRY (G-COR) US PILOT STUDY: EARLY COHORT BREAST CANCER PATIENTS DEMOGRAPHICS AND EXERCISE HABITS.
99. Singh S, Miller C, Song J, Ali A, Cervoni-Curet F, Iliescu C, Khalaf S, Hamzeh I, Palaskas NL, Deswal A, Becnel M, Koutroumpakis AE. ECHOCARDIOGRAPHIC ASSESSMENT OF THE LEFT AND RIGHT ATRIUM IN SYSTEMIC AL AMYLOIDOSIS WITH AND WITHOUT CARDIAC INVOLVEMENT.
100. Koutroumpakis E, Venkatesh N, Aparicio A, Song J, Deswal A, Logothetis C, Frigo D, Hahn AA. THE BURDEN OF SUBCLINICAL CORONARY ARTERY DISEASE AS MEASURED BY CORONARY ARTERY CALCIFICATION AND ASSOCIATION WITH LEPTIN LEVELS IN PATIENTS WITH METASTATIC PROSTATE CANCER.
101. Ali A, Ebied A, Koutroumpakis E, Monlezun D, Sakr M, Osama M, Lee M, Marmagkiolis K, Aziz MK, Guha A, Deswal A, Iliescu AC. CARDIOVASCULAR MORTALITY TRENDS IN PROSTATE CANCER PATIENTS: INSIGHTS FROM THE SEER 17 DATABASE (2010-2015).

Book Chapters

1. Tyler M, Deswal A, Misra A. Heart Failure with Preserved Ejection Fraction. In: Cardiovascular Medicine and Surgery. First. Wolters Kluwer, 2022.
2. Nair, Mohammed S, Agarwal N, Deswal A. Sex Differences in Pulmonary Hypertension. In: Sex Differences in Pathophysiology, Presentation, Diagnosis and Management of Cardiac Disease. Elsevier, 2021.
3. Mohammed S, Nair A, Aggarwal N, Deswal A. Sex Differences in Heart Failure with Preserved Ejection Fraction. In: in Sex-Differences in Pathophysiology, Presentation, Diagnosis and Management of Cardiac Disease. Elsevier, 2021.
4. Fedson S, Misra A, Deswal A. Treatment of Heart Failure with Preserved Ejection Fraction. In: Heart Failure-a companion to Braunwald’s Heart Disease. 4. Saunders Elsevier, 2019.
5. Kayani W, Deswal A. Neurohormonal Blockade. In: Color Atlas and Synopsis of Heart Failure. 1. McGraw Hill, 2018.
6. Cunningham L, Kayani W, Deswal A. Neurohormonal Blockade. In: The Encyclopedia of Cardiovascular Research and Medicine. Elsevier, 459-476, 2018.
7. Khalid U, Deswal A. Heart Failure with Preserved Ejection Fraction. In: Cardiology Secrets. 5. Elsevier, Inc, 2017.
8. Sean Pinney EQWC, Colvin MM, Deswal A, Fedson S, Givertz M, Goldberg L, Lewis E, Panjrath G, Sam F, Semigran M, Shah T, Smart F, Uriel N. Online Advanced Heart Failure & Transplant Cardiology Self-Assessment Questions and Board Prep Program. In: American College of Cardiology, 2016.
9. Levine G, Deswal A, Blaustein A. Normal Valvular Anatomy and Function. In: Illustrated Guide to Cardiovascular Disease. Jaypee Medical Science Publishers, 2016.
10. Deswal A. Treatment of Heart Failure with Preserved Ejection Fraction. In: Heart Failure-a companion to Braunwald’s Heart Disease. 3. Saunders Elsevier, 2016.
11. Levine G, Deswal A, Blaustein A. Normal Valvular Anatomy and Function. In: Color Atlas of Cardiovascular Disease. Jaypee Medical Science Publishers, 2015.
12. Ather, S, Deswal, A. Heart Failure with Preserved Ejection Fraction. In: Cardiology Secrets. 4th edition. Elsevier, 185-191, 2013.
13. Bozkurt B, Deswal A. Angiotensin Receptor Blockers. In: Clinical Decision Support: Cardiology a digital program on Cardiology, 2013.
14. Ather S, Deswal A. Heart Failure with Preserved Ejection Fraction. In: Cardiology Secrets. 4. Elsevier, Inc, 2012.
15. Ramasubbu, K, Deswal, A. Emerging Strategies in the Treatment of Heart Failure. In: Heart Failure: A Companion to Braunwald's Heart Disease. 2nd Edition. Elsevier, 728-741, 2011.
16. Bozkurt B, Deswal A, Mann DL. Role of Inflammatory Biomarkers in Heart Failure. In: Cardiac Biomarkers in Modern Medicine: Practical Knowledge for the Clinician. Sudbury, 2011.
17. Deswal, A. Treatment of Heart Failure with a Preserved Ejection Fraction. In: Heart Failure: A Companion to Braunwald's Heart Disease. 2nd Edition. Elsevier, 704-715, 2011.
18. Ramasubbu K, Deswal A. Medical Treatment of Systolic Heart Failure. In: Cardiology Board Review. McGraw Hill, 2011.
19. Ramasubbu K, Deswal A. Emerging Strategies in the Treatment of Heart Failure. In: Heart Failure-a companion to Braunwald’s Heart Disease. Saunders Elsevier, 2010.
20. Deswal A. Treatment of Heart Failure with Preserved Ejection Fraction. In: Heart Failure-a companion to Braunwald’s Heart Disease. Saunders Elsevier, 2010.
21. Ramasubbu, K, Deswal, A. Inhibitors of the Renin-Angiotensin-Aldosterone System. In: Cardiology Secrets. 3rd Edition. Elsevier, 163-170, 2010.
22. Nguyen, JS, Deswal, A. Heart Failure with Preserved Ejection Fraction. In: Cardiology Secrets. 2nd Edition. Elsevier, 176-181, 2010.
23. Nguyen J, Deswal A. Heart Failure with Preserved Ejection Fraction: Diastolic Dysfunction. In: Cardiology Secrets. 3. Elsevier, Inc, 2009.
24. Ramasubbu K, Deswal A. Treatment of Heart Failure: Inhibitors of the Renin Angiotensin Aldosterone System. In: Cardiology Secrets. 3. Elsevier, Inc, 2009.
25. Deswal, A, Mann, D. Angiotensin Receptor Blockers in the Treatment of Heart Failure. In: Heart Failure: Pharmacologic Management. Blackwell Publishing, 44-56, 2007.
26. Deswal A, Mann DL. Angiotensin Receptor Blockers in Heart Failure. In: Cardiovascular Therapeutics. Blackwell Publishing Ltd, 2006.
27. Deswal A, Bozkurt B, Mann DL. The Clinical Experience with Anti-Cytokine Therapy in Heart Failure. In: Inflammation and Cardiac Diseases. Birkhauser Verlag, 2003.
28. Deswal A, Barger P, Maclellan R, Mann D L. Emerging Strategies in the Treatment of Heart Failure. In: Heart Failure-a Companion to Braunwald’s Heart Disease. Saunders, 2003.
29. Deswal A, Misra A, Bozkurt B. The Role of Anti-cytokine Therapy in the Failing Heart. In: The Role of Inflammatory Mediators in the Failing Heart. Kluwer Academic Publishers, 2001.
30. Deswal A, Follansbee WP. Cardiac Involvement in Scleroderma. 4. Rheum Dis Clin North Am, 841-60, 1996.
31. Kumar S, Deswal A. Cardio-Oncology and Heart Failure. In: Heart Failure: A Companion to Braunwald’s Heart Disease. 5th Edition. Elsevier.

Books (edited and written)

1. . Cancer and Cardiovascular Disease: A Concise Clinical Atlas. Ed(s) Second. Springer Nature.

Letters to the Editor

1. Borlaug BA, Chen H, Lin G, Redfield MM, Lewis GD, Semigran MJ, McNulty SE, LeWinter M, Deswal A, Margulies KB. Response to Letter Regarding Article, “Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction”. Circ Heart Fail 8(4):840, 2015.
2. Deswal, A, Patel, P. β-Blockers in systolic heart failure. American Heart Journal 154: e25, 2007.
3. Deswal A, Patel P. Beta-Blockers in systolic heart failure: Do physicians need more courage? Response to the Letter. Am Heart J 154:e25, 2007.